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Abstract
Osteopenia is a well documented complication of anorexia nervosa (AN). The
pathogenesis of this bone loss is presently poorly defined in the literature.
Pathogenetic mechanisms that have been implicated include certain nutritional
factors, exercise abuse, hypogonadism, hypercortisolism and/or vitamin 0
deficiency.
We studied, 59 Caucasian eating disorder patients aged 15-45yr. The eating
disorder was classified by a single, qualified psychiatrist according to OSM IV R
criteria as either anorexia nervosa (AN: n =25), bulimia nervosa (BN: n = 17) or
eating disorder not otherwise specified (EONOS: n = 17). All patients were
subjected to a detailed dietary and general history. We assessed the prevalence
and severity (OEXA), the nature (osteocalcin, deoxypyridinoline) and site
(vertebral versus hip) of osteopenla in these patients. he role of nutritional
factors (energy intake, weight, height, BMI, plasma albumin, lipids), physical
activity, hypercortisolemia (plasma and urinary free cortisol), vitamin 0 deficiency
(plasma 250HD) and hypogonadism (amenorrhoea, E2, LH, FSH) in the
pathogenesis of bone loss were also evaluated.
Mild osteopenia (BMO decreased by more than 1SO below age-matched
controls) was documented in 46% of the total study population, with more
marked osteopenia (Z-Score < -2 SO) present in 15%. Both vertebral and hip
osteopenia were documented. In the study population those patients with AN
(Lumbar BMO (q/cm") = 0.869 ± 0.121) were most likely to develop osteoporosis,
although a significant percentage of patients with BN (Lumbar BMO (q/crn") =
0.975 ± 0.16) and EONOS (Lumbar BMO (g/cm2) = 0.936 ± 0.10) were also
osteopenic (29% and 35% respectively). Twenty four percent (24%) of the total
patient population had a history of fragility fractures. These fractures were
reported more commonly amongst patients with AN and EONOS (28% and
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29.4%). Fracture prevalence was however similar in patients with normal and low
bone mass.
Conventional risk factors were similar in patients with normal and low bone
mass, except for a significantly longer duration of amenorrhoea (p = 0.009), a
lower BMI (p = 0.0001) and greater alcohol consumption (p = 0.05) in the
osteopenic patients. Nutritional parameters (S-albumin, protein, Ca, and P04
intakes), physical activity, as well as 25(OH) vitamin D levels were similar in AN
and BN subjects, as well as in patients with a low versus normal BMD. Plasma
and urine cortisol levels were also similar in these subgroups.
With the exception of two patients with borderline osteopenia, significant bone
loss was only documented in those patients with a past or current history of
amenorrhoea. In the total patient population the duration of amenorrhoea was
significantly (p<0.009) longer in patients with osteopenia versus those with a
normal bone mass. A significant negative correlation between BMD (Z-Score)
and duration of amenorrhoea was also documented in the total patient
population (r = -0.4, P = 0.001) as well as in all three eating disorder groups (AN r
- -0.4, P = 0.03; BN r = - 0.6, P = 0.008; EDNOS r = -0.6, P = 0.005).
In the total patient population, those patients with amenorrhoea, had lower BMD
and BMI values and lower estrogen levels compared to those with a normal
menstrual cycle.
We conclude that osteopenia commonly attends AN, as well as BN and EDNOS.
Nutritional (with the exception of alcohol consumption) and mechanical factors as
well as hypercortisolemia did not appear to contribute significantly to bone loss in
this study population. Hypogonadism appeared to be the main cause of the bone
loss observed in these patients.
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Abstrak
Osteopenie is In welbekende komplikasie van anorexia nervosa (AN). Die
patogenese van hierdie beenverlies is swak in die huidige literatuur omskryf en
nutrisiele faktore, 'n vitamien 0 gebrek, oormatige oefening, hiperkortisolemie en
hipogonadisme word onder andere qeimpliseer.
Vir die doel van die studie is In totaal van 59 Kaukasier eetsteurnis pasiente
patients volledig ondersoek. Die tipe eetsteurnis is deur In enkel gekwalifiseerde
psigiater volgens die DSM IV R kriteria geklassifiseer as anorexia nervosa (AN: n
=25) of bulimia nervosa (BN: n = 17) of eetsteurnis nie anders gespesifiseer
(EDNOS: n = 17). Elke pasient is ook aan In gedetailleerde dieet en algemene
risikofaktor vraelys vir osteoporose onderwerp. Die voorkoms en graad (DEXA),
die aard (osteokalsien, deoksipiridinolien) asook die tipe (werwelkolom/heup)
osteopenie is ondersoek. Die rol van nutrisiele faktore (totale kalorie-inmame,
gewig ,Iente LMI, plasma albumien, lipiede) en vitamien 0 gebrek, oefening,
hiperkortisolemie (plasma en urinere kortisol) en hipogonadisme (amenoree,
plasma E2, LH,FSH) in die patogenese van die beenverlies is ook evalueer.
Matige osteopenie (BMD meer as 1 SO onder die van ouderdomskontrole) is in
46% van die totale pasientpopulasie gedokumenteer, met erge osteopenie
(Z-Telling < -2) in 15%. Aantasting van beide werwelkolom en heup is
aangetoon. In hierdie studiepopulasie kom osteopenie meer algemeen voor in
die AN (Lumbaal BMD (g/cm2) = 0.869 ± 0.121) groep (64%) in vergelyking met
BN (Lumbaal BMD (g/cm2) = 0.975 ± 0.16) (29%) en (EDNOS) (Lumbaal BMD
(g/cm2) = 0.936 ± 0.10) (32%). Vier-en-twintig persent van die totale
pasientpopulasie het In geskiedenis van frakture gehad. Frakture het meer
algemeen in AN en EDNOS pasiente voorgekom (28% en 29%).
Pasiente met 'n lae beenmassa was gekenmerk deur In betekenisvolle laer LMI
(p = 0.0001), hoer alkolholverbruik (p = 0.05) en langer duurte van amenoree
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(p = 0.009). Nutrisiele parameters (s-albumien, protetene, Ca, P04 inname)
oefening, asook 25(OH) vitamien 0 vlakke was soortgelyk in AN en BN pasiente.
Hierdie parameters het ook nie verskil tussen pasiente met osteopenie en die
met In normale BMD nie. Plasma en urinere vry kortisolvlakke was ook
soortgelyk in hierdie twee groepe.
Betekenisvolle beenverlies (met die uitsondering van twee pasiente met grenslyn
osteopenie) het slegs voorgekom in pasiete met 'n huidige of In vorige
geskiedenis van amenoree. In die totale pasientpopulasie was die duurte van
amenoree (p< 0.009) betekenisvollanger in die pasiente met osteopenie. In
Betekenisvolle negatiewe korrelasie tussen BMD (Z-Telling) en die duurte van
amenoree in die toale pasient populasie (r = -0.4; P = 0.001) asook in al drie
eetsteurnis groepe (AN: r = -0.4; P = 0.03; BN: r = -0.06; P = 0.008; EDNOS: r = -
0.6, P = 0.005) is aangetoon. In die groep as 'n geheel, het die amenoree
pasiente In laer LMI, E2vlakke en BMD gehad in vergelyking met die pasiente
met normale menses.
Opsommend dus, kom osteopenie algemeen in pasiente met AN, asook BN en
EDNOS voor. In Betekenisvolle bydrae van nutrisiele (met die uitsondering van
alkoholinname) en meganiese faktore asook hiperkortisolemie tot been verlies,
kon nie in hierdie tudie populasie gedemonstreer word nie. Hipogonadisme is as
die hoofoorsaak van osteopenie in die pasiente qefdentifiseer.
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Abstract
Osteopenia is a well documented complication of anorexia nervosa (AN). The
pathogenesis of this bone loss is presently poorly defined in the literature.
Pathogenetic mechanisms that have been implicated include certain nutritional
factors, exercise abuse, hypogonadism, hypercortisolism and/or vitamin D
deficiency.
We studied, 59 Caucasian eating disorder patients aged 15-45yr. The eating
disorder was classified by a single, qualified psychiatrist according to DSM IV R
criteria as either anorexia nervosa (AN: n =25), bulimia nervosa (BN: n = 17) or
eating disorder not otherwise specified (EDNOS: n = 17). All patients were
subjected to a detailed dietary and general history. We assessed the prevalence
and severity (DEXA), the nature (osteocalcin, deoxypyridinoline) and site
(vertebral versus hip) of osteopenia in these patients. The role of nutritional
factors (energy intake, weight, height, BMI, plasma albumin, lipids), physical
activity, hypercortisolemia (plasma and urinary free cortisol), vitamin D deficiency
(plasma 250HD) and hypogonadism (amenorrhoea, E2, LH, FSH) in the
pathogenesis of bone loss were also evaluated.
Mild osteopenia (BMD decreased by more than 1SD below age-matched
controls) was documented in 46% of the total study population, with more
marked osteopenia (Z-Score < -2 SO) present in 15%. Both vertebral and hip
osteopenia were documented. In the study population those patients with AN
(Lumbar BMD (g/cm2) = 0.869 ± 0.121) were most likely to develop osteoporosis,
although a significant percentage of patients with BN (Lumbar BMD (g/cm2) =
0.975 ± 0.16) and EDNOS (Lumbar BMD (g/cm2) = 0.936 ± 0.10) were also
osteopenic (29% and 35% respectively). Twenty four percent (24%) of the total
patient population had a history of fragility fractures. These fractures were
reported more commonly amongst patients with AN and EDNOS (28% and
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29.4%). Fracture prevalence was however similar in patients with normal and low
bone mass.
Conventional risk factors were similar in patients with normal and low bone
mass, except for a significantly longer duration of amenorrhoea (p = 0.009), a
lower BMI (p = 0.0001) and greater alcohol consumption (p = 0.05) in the
osteopenic patients. Nutritional parameters (S-albumin, protein, Ca, and P04
intakes), physical activity, as well as 25(OH) vitamin 0 levels were similar in AN
and BN subjects, as well as in patients with a low versus normal BMD. Plasma
and urine cortisol levels were also similar in these subgroups.
With the exception of two patients with borderline osteopenia, significant bone
loss was only documented in those patients with a past or current history of
amenorrhoea. In the total patient population the duration of amenorrhoea was
significantly (p<0.009) longer in patients with osteopenia versus those with a
normal bone mass. A Significant negative correlation between BMD (Z-Score)
and duration of amenorrhoea was also documented in the total patient
population (r = -0.4, P = 0.001) as well as in all three eating disorder groups (AN r
- -0.4, P = 0.03; BN r = - 0.6, P = 0.008; EDNOS r = -0.6, P = 0.005).
In the total patient population, those patients with amenorrhoea, had lower BMD
and BMI values and lower estrogen levels compared to those with a normal
menstrual cycle.
We conclude that osteopenia commonly attends AN, as well as BN and EDNOS.
Nutritional (with the exception of alcohol consumption) and mechanical factors as
well as hypercortisolemia did not appear to contribute significantly to bone loss in
this study population. Hypogonadism appeared to be the main cause of the bone
loss observed in these patients.
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Abstrak
Osteopenie is In welbekende komplikasie van anorexia nervosa (AN). Die
patogenese van hierdie beenverlies is swak in die huidige literatuur omskryf en
nutrisiele faktore, In vitamien D gebrek, oormatige oefening, hiperkortisolemie en
hipogonadisme word onder andere geYmpliseer.
Vir die doel van die studie is In totaal van 59 Kaukasier eetsteurnis pasiente
patients volledig ondersoek. Die tipe eetsteurnis is deur In enkel gekwalifiseerde
psigiater volgens die DSM IV R kriteria geklassifiseer as anorexia nervosa (AN: n
=25) of bulimia nervosa (BN: n = 17) of eetsteurnis nie anders gespesifiseer
(EDNOS: n = 17). Elke pasient is ook aan In gedetailleerde dieet en algemene
risikofaktor vraelys vir osteoporose onderwerp. Die voorkoms en graad (DEXA),
die aard (osteokalsien, deoksipiridinolien) asook die tipe (werwelkolom/heup)
osteopenie is ondersoek. Die rol van nutrisiele faktore (totale kalorie-inmame,
gewig ,Iente LMI, plasma albumien, lipiede) en vitamien D gebrek, oefening,
hiperkortisolemie (plasma en urinere kortisol) en hipogonadisme (amenoree,
plasma E2, LH,FSH) in die patogenese van die beenverlies is ook evalueer.
Matige osteopenie (BMD meer as 1 SD onder die van ouderdomskontrole) is in
46% van die totale pasientpopulasie gedokumenteer, met erge osteopenie
(Z-Telling < -2) in 15%. Aantasting van beide werwelkolom en heup is
aangetoon. In hierdie studiepopulasie kom osteopenie meer algemeen voor in
die AN (Lumbaal BMD (g/cm2) = 0.869 ± 0.121) groep (64%) in vergelyking met
BN (Lumbaal BMD (g/cm2) = 0.975 ± 0.16) (29%) en (EDNOS) (Lumbaal BMD
(g/cm2) = 0.936 ± 0.10) (32%). Vier-en-twintig persent van die totale
pasientpopulasie het In geskiedenis van frakture gehad. Frakture het meer
algemeen in AN en EDNOS pasiente voorgekom (28% en 29%).
Pasiente met In lae beenmassa was gekenmerk deur In betekenisvolle laer LMI
(p = 0.0001), hcer alkolholverbruik (p = 0.05) en langer duurte van amenoree
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(p = 0.009). Nutrisiele parameters (s-albumien, proteiene, Ca, P04 inname)
oefening, asook 25(OH) vitamien 0 vlakke was soortgelyk in AN en BN pasiente.
Hierdie parameters het ook nie verskil tussen pasiente met osteopenie en die
met In normale BMD nie. Plasma en urinere vry kortisolvlakke was ook
soortgelyk in hierdie twee groepe.
Betekenisvolle beenverlies (met die uitsondering van twee pasiente met grenslyn
osteopenie) het slegs voorgekom in pasiete met In huidige of In vorige
geskiedenis van amenoree. In die totale pasientpopulasie was die duurte van
amenoree (p< 0.009) betekenisvollanger in die pasiente met osteopenie. In
Betekenisvolle negatiewe korrelasie tussen BMD (Z-Telling) en die duurte van
amenoree in die toale pasient populasie (r = -0.4; P = 0.001) asook in al drie
eetsteurnis groepe (AN: r = -0.4; P = 0.03; BN: r = -0.06; P = 0.008; EDNOS: r = -
0.6, P = 0.005) is aangetoon. In die groep as In geheel, het die amenoree
pasiente In laer LMI, E2vlakke en BMD gehad in vergelyking met die pasiente
met normale menses.
Opsommend dus, kom osteopenie algemeen in pasiente met AN, asook BN en
EDNOS voor. In Betekenisvolle bydrae van nutrisiele (met die uitsondering van
alkoholinname) en meganiese faktore asook hiperkortisolemie tot been verlies,
kon nie in hierdie tudie populasie gedemonstreer word nie. Hipogonadisme is as
die hoofoorsaak van osteopenie in die pasiente geYdentifiseer.
Stellenbosch University http://scholar.sun.ac.za
vORAL PRESENTATIONS
1. Conradie MM, Jordaan G, Hough FS. Bone and Mineral Metabolism in Eating
Disorders: A Preliminary Report. Oral presentation at the s" Bone and
Mineral Congress. 6 - 10 April 1997, Pilanesberg
2. Conradie MM, Jordaan G, Hough FS. Bone and Mineral Metabolism in Eating
Disorders. Oral presentation at the 1st Annual Zeneca Medical Research Day.
12 August 1998, Medical School, University of Cape Town
3. Conradie MM, Jordaan G, Hough FS. Die Effek van Eetsteurnisse op Been
en Mineraal Metabolisme. Voordrag op 42ste Akademiese Jaardag. 19 - 20
Augustus 1998, Fakulteite van Geneeskunde en Tandeelkunde, Universiteit
van Stellenboch
4. Conradie MM, Jordaan G, Hough FS. Bone and Mineral Metabolism in Eating
Disorders. Oral presentation at the s" Bone and Mineral Metabolism
Congress. 17 - 22 April, Drakensberg
Stellenbosch University http://scholar.sun.ac.za
vi
ACKNOWLEDGEMENTS
I wish to express my sincere appreciation and heartfelt thanks to the following
people:
Prof. Stephen Hough, my promotor, for his interest, constructive criticism and
guidance.
Dr. Gerhard Jordaan for the classification of patients in the eating disorder
subgroups and for his support.
The nursing staff of the Endocrine and Metabolic Unit, for the venesections.
Dr Magda Conradie for expert advice, guidance and moral support throughout.
Special thanks to my friends and family who provided me with constant
encouragement and inspiration - I truly cherish your love and friendship.
And - I to Him who sits on the throne and to the Lamb be praise and honour and
glory and power, for ever and ever! '
Stellenbosch University http://scholar.sun.ac.za
vii
LIST OF ABBREVIATIOBS
ALP
AN
BMO
BMI
BN
Cr
OEXA
OPO
E2
EONOS
FSH
GH
IGF 1
IRMA
LH
NIH
PTH
ROA
SHBG
T4
TRP%
T-Score
TSH
Z-Score
alkaline phosphatase
anorexia nervosa
bone mineral density
body mass index
bulimia nervosa
creatinine
dual energy X-ray absorptiometry
deoxypyridinoline
estrogen
eating disorder not otherwise specified
follicle stimulating hormone
growth hormone
insulin-like growth factor 1
immunoradiometric assay
luteinizing hormone
National Institute of Health
parathyroid hormone
recommended daily allowance
sex hormone binding globulin
thyroxine
tubular reabsorption of phosphate (%)
bone mineral density compared to the young reference mean
thyroid stimulating hormone
bone mineral density compared to age and sex matched controls
Stellenbosch University http://scholar.sun.ac.za
viii
ADDENDA
I. Risikofaktor Vraelys
II. Risk Factor Questionnaire
III. Dieet Inligting
IV. Diet Information
Stellenbosch University http://scholar.sun.ac.za
CHAPTER 1
RESEARCH OBJECTIVES
The eating disorder, Anorexia Nervosa (AN) predisposes to low bone mineral
density, with osteopenia occurring in up to 50% of affected patients. This
association between AN and osteopenia was first reported in the literature in the
early 19805 (Rigotti et ai, 1984) and consistently confirmed in follow up studies
(Brotmen and Stern, 1985; Rigotti et ai, 1991; Salisbury and Mitchell, 1991; Hay
et ai, 1992). A higher fracture risk has also been documented in this condition.
(Verbruggen et. ai, 1993; Kaplan et ai, 1986). Data regarding the association
between bone mass status and other eating disorders i.e. Bulimia Nervosa (BN)
and Eating Disorder Not Otherwise Specified (EDNOS) are limited and
conflicting.
The pathogenesis of bone loss in eating disorder patients remains incompletely
understood and appears to be complex. Mechanisms implicated in this disease
process include nutritional factors, exercise abuse, associated hypogonadism
and more recently, chronic stress and hypercortisolemia.
This comparative study amongst the three eating disorder groups (i.e. AN, BN,
EDNOS) specifically aimed to:
1. Determine the - prevalence,
- biochemical nature (i.e. low versus high turnover) and
- clinical type (i.e. vertebral versus hip)
of osteopenia in the study populations.
2. Compare the presence of clinical risk factors previously shown to predispose
Caucasian women to osteoporosis.
- In the three different eating disorder groups and
- in subgroups with a normal and low bone mineral density (BMD).
3. Gain insight into the pathoqenesis of osteopenia in this study population,
specifically with regard to:
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2- Nutritional factors
- Mechanical factors including physical exercise
- Hypogonadism
- Hypercortisolemia
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3CHAPTER 2
GENERAL BACKGROUND
A. OSTEOPOROSIS
1. Introduction
Osteoporosis is a progressive systemic skeletal disease characterized by low
bone mass and microarchitectural deterioration of bone tissue, with a consequent
increase in bone fragility and susceptibility to fracture (Kanis et aI, 1997). It is a
major health problem through its association with fractures, which typically occur
at the hip, vertebra and wrist.
2. Epidemiology
Uncomplicated osteoporosis does not cause symptoms. Patients with
osteoporosis do not seek medical aid until complications occur, generally a
fracture, loss of height or back pain. Osteoporosis occurs in all population
groups although it is more common in Caucazoids. Recent evidence indicates
that the incidence of osteoporosis is increasing. This disease affects more than
one-third of Caucasion women over age 50 and nearly half of all individuals over
age 70 (Kanis, 1994).
The prevalence of osteoporosis of the femoral neck increases from 5.1% at 50-
54 years, to over 60% at age 85 or more. Spinal osteoporosis is 6 times and hip
fractures 2-3 times more common in women than in men (Hiller and Cooper,
1997). Osteoporotic fractures of the spine and the forearm are associated with
significant morbidity, but the most serious consequences arise in patients with
hip fractures, which is associated with a significant increase in mortality (15-
20%), particularly in the elderly (Kanis et aI, 1997).
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43. Pathogenesis of osteoporosis
3.1. Bone composition and structure
Bone is a metabolically active living tissue, which is continually formed and
resorbed by bone cells. Activity of these bone cells is modified by many factors,
including normal growth, the external environment as well as endocrine- and
nutritional factors, physical activity and local growth factors. Two types of bone
are found in the body, namely cortical and trabecular bone. Cortical bone
predominates in the shafts of the long bones and trabecular bone is concentrated
in the vertebrae, in the pelvis and other flat bones and in the ends of long bones.
Trabecular bone, with its greater surface area,
is metabolically much more active than cortical
bone and therefore more responsive to
changes in mineral homeostasis (Riggs and
Melton, 1986).
3.2. Bone remodeling (Figure 1)
Bone formation and bone resorption do not
occur randomly throughout the skeleton.
Rather, they follow a programmed sequence at
discrete foci called bone-remodeling units.
Remodeling is the process of bone resorption
followed by bone formation and provides a
mechanism for self-repair and adaptation to
stress. Activation is the process by which the
quiescent bone surface is prepared for
resorption. Osteoclasts appear on a previously
inactive surface and, over a period of about two
weeks construct a tunnel in cortical bone or a
lacuna on the surface of trabecular bone. The
osteoclasts are replaced by osteoblasts,
which fill in the resorption cavity with
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Diagram to illustrate the process
of bone remodeling
Adapted from: Compston, 1997
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5immature unmineralised bone over a period of three to four months. The latter is
subsequently mineralised to create a new structural unit of bone. The rate of one
turnover cycle is determined mainly by the frequency of activation of new bone-
remodeling units. In normal young adults, the resorption and formation phases
are tightly coupled and bone mass is maintained. This is accomplished by a
variety of chemical factors (e.g. hormones, minerals) as well as physical
influences (e.g. exercise) which affect the activity of the bone cells.
3.3. Life time changes in bone mass
Bones grow in size during the first two decades of life, with a spurt during
adolescence. This is followed by a period of consolidation. Peak adult bone
mass is reached at about the age of 30 years for cortical bone and a little earlier
for trabecular bone. After 9 35, bone resorption exceeds bone formation,
resulting in a progressive decline in bone mass (age-related bone loss) (Riggs
and Melton, 1986).
3.4. Pathophysiology of bone loss
Bone loss implies an uncoupling of the phases of bone remodeling, with a
relative or absolute increase in resorption and lor inadequate formation. There
are two basic mechanisms of bone loss, namely increased activation frequency
and remodelling imbalance. Increased activation frequency implies an increase
in the number of remodelling units on the bone surface. This leads to increased
resorption and bone turnover. Remodelling imbalance occurs within the
remodelling units and implies an imbalance between formation and resorption,
favouring the latter.
Menopausal bone loss in women is associated with both increased activation
frequency and remodelling imbalance. Age related bone loss in males and
females however, are the result of remodelling imbalance only.
Stellenbosch University http://scholar.sun.ac.za
64. Risk factors for the development of osteoporosis
The most important clinical endpoint of osteoporosis is a bony fracture. A
combination of skeletal fragility and the risk of sustaining a fall determine the risk
of fracture. Differences in bone mineral density (BMD) account for 60-90% of the
variation in bone fragility and are the most commonly used method of assessing
a subject's risk of fracture (Arden, 1997). An individual's bone mass is a function
of peak bone mass attained and subsequent losses. Osteoporosis may arise
from abnormalities at all stages of skeletal life and it is therefore more useful to
consider osteoporosis as a multifactorial disease, largely determined by genetic,
life-style and ageing factors as well as a variety of medical diseases.
4.1. Genetic factors
A number of studies suggest that peak bone mass and to a lesser extent
involutional bone loss are genetically determined. Recent studies suggest that,
in some countries, approximately 50% of the apparent heritability may be
associated with polymorph isms in the genes coding for the vitamin D receptor,
the estrogen receptor, growth factors, or collagen (Arden, 1997).
Body mass is an important determinant of peak bone mass. It is also an
essential factor in the development and maintenance of BMD at all ages.
Although it is obvious that large people have larger bones, body weight is a more
important factor than stature per se. Excessive leanness (BMI < 19k9/m2) is
undoubtedly an important risk factor for the development of osteoporosis (Kanis
eta/,1997).
4.2. Life-style
4.2.1. Reproductive history
Estrogen is an important anti-resorptive agent. All causes of hypogonadism,
including the natural menopause, cause loss of skeletal mass. Examples of
reversible premature gonadal dysfunction include anorexia nervosa, exercise
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7induced gonadal failure and pituitary tumours including prolactinomas. The
natural menopause is by far the most common cause of hypogonadal
osteoporosis. Accelerated postmenopausal bone loss puts women at
substantially higher risk of osteoporotic fractures than men. An early menopause
«age 45 years) increases this risk.
4.2.2. Smoking
Cigarette smoking has an adverse influence on bone mineral density. Several
mechanisms have been described whereby smoking may reduce BMD. These
include lower body mass and reduced circulating estrogen levels in females
(Aden, 1997).
4.2.3. Alcohol
Alcohol abuse appears to be a significant risk factor for osteoporosis. The
association between moderate alcohol consumption and bone density is less
clear. A direct toxic effect of alcohol on bone has been described, resulting in
reduced rates of bone formation. A high intake of alcohol is also associated with
marked dietary disturbances such as protein undernutrition, liver disease,
hypogonadism and other changes in lifestyle such as smoking and a lack of
exercise (Bikle, 1993). Alcohol abuse further increases fracture risk by
enhancing the propensity to a fall. Premenopausal women and men appear to be
at particular risk, while postmenopausal females with moderate alcohol
consumption may in fact have a decreased risk of fracture (Bikle, 1993; Arden,
1997).
4.2.4. Physical activity
Physical activity may be beneficial or harmful to bone. Exercise, especially if
weight bearing, has been shown to stimulate bone formation whereas excessive
exercise adversely influences bone health. Physical loading of bone is essential
for the normal growth and development of the skeleton and is very important to
ensure attainment of optimal peak bone mass. Bone responds rapidly to any
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8loss of physical loading (e.g. weightlessness in space, immobilisation). The type
of activity may also be significant (weight bearing i.e. running, non-weight bearing
i.e. swimming). Ordinary daily activity and moderate exercise may have little or
no effect on BMD in healthy young women (Kanis, 1994).
4.2.5. Nutrition
Undernutrition has many causes such as poverty, famine, ignorance, anorexia
and depression. An adequate calcium intake is required to attain genetically
determined peak bone mass and to maintain this (Kanis et aI, 1997). Adequate
calcium nutrition is especially important in the elderly - when accompanied by
vitamin 0 deficiency, secondary hyperparathyroidism or even frank osteomalacia
may occur. Protein-calorie malnutrition leads to weak muscles and poor co-
ordination and to loss of soft tissue padding over the hips. High protein diets
have been associated with adverse effects on calcium metabolism, including
hypercalcuria (Younghee and Linkswiler, 1979; Arden, 1997). High intakes of
caffeine-containing drinks are also associated with an increased urinary calcium
excretion (Arden, 1997). Other dietary constituents may be important and are
currently under investigation. These include fibre, vitamin K, vitamin C,
magnesium and various trace elements.
4.3. Ageing
Ageing is associated with progressive osteoblast incompetence, hypogonadism,
a negative calcium balance and secondary hyperparathyroidism as well as an
increased propensity to falling.
4.4. Diseases and drugs associated with osteoporosis
There are a large number of underlying conditions known to cause osteoporosis.
Secondary causes of osteoporosis may be found in up to 30% of women and
54% of men with symptomatic vertebral crush fractures (Anderson and Francis,
1997). The most frequently encountered secondary causes of osteoporosis are
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9steroid therapy, myeloma, skeletal metastases and endocrine disorders like
hypogonadism and hyperthyroidism (Table 1).
Table 1: Causes of Secondary Osteoporosis
Causes of Secondary Osteoporosis
Endocrine
Amenorrhoea
Male hypogonadism
Amenorrheic athletes
Hyperthyroidism
Eating disorders (Anorexia
Hyperparathyroidism
Nervosa)
Hypercortisolism
Hyperprolactinem ia
Diabetes (Type 1)
Drugs
Corticosteroids Immunosuppressive therapy
Excessive thyroid replacement therapy Heparin
Anticonvulsants Gonadotropin-releasing hormone
Chemotherapy agonists/antagonists
Chronic phosphate binding antacids Tamoxifen (premenopausal use)
Aluminium Long-term lithium therapy
Prolonged parenteral nutrition
Neoplastic disease
Multiple myeloma
Skeletal metastases
Other conditions
Transplantation Rheumatoid arthritis
Gastric surgery Immobilization
Celiac disease Osteogenesis imperfecta
Inflammatory Bone Disease Homocystinuria
Alcoholism Systemic mastocytosis
Pregnancy
,
7.1. S. •
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5. Diagnosis of osteoporosis
5.1. Definitions of osteoporosis
Osteoporosis is a systemic skeletal disease characterised by low bone mass and
micro-architectural deterioration of bone tissue, with a consequent increase in
bone fragility and susceptibility to fracture (Hiller and Cooper, 1997; Kanis et aI,
1997). Given the fact that a low bone mass (bone mineral density, BMO)
constitutes the most important risk factor for fracture, the World Health
Organisation (WHO, 1994) has recently defined osteoporosis as follows:
Table 2: World Health Organization classification of osteoporosis.
World Health Organization Classification of Osteoporosis
Definition Criteria
BMC or BMO value within1 so of the young
Normal normal mean
BMC or BMO 1-2.5 SO below the young
Low bone mass (osteopenia) normal mean
BMC or BMO more than 2.5 SO below the
Osteoporosis young normal mean
Osteoporosis (above) with one or more
Established osteoporosis fragility fractures
BMO = bone mineral density, BMC = bone mineral content, SO = standard deviation.
Adapted from: World Health Organization (WHO) Study Group, 1994
5.1.1 Limitations of current definitions of Osteoporosis
While the WHO classification of osteoporosis has provided a practical basis to
identify postmenopausal Caucasian women at risk of sustaining a fracture, it has
limitations. The WHO criteria are exclusively based on data obtained for
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Caucasian, postmenopausal women, employing dual energy X-ray
absorptiometry (OEXA) of the axial (hip, spine) skeleton. Extrapolation of these
criteria to other populations (ethnic groups, young individuals, males) assessed
with different techniques, at different sites, is not acceptable. For this reason,
most studies (Carmichael and Carmichael, 1995; Grinspoon et aI, 1996a; Ward
et el, 1997; Gordon et aI, 1999; Soyka et aI, 1999; Treasure and Serpell, 1999)
assessing osteopenia/osteoporosis in young eating disorder subjects, many of
whom have not reached a peak BMO, have employed age-matched, control BMD
values (so called Z-scores).
5.2. Bone Mass Measurement
A number of techniques, able to measure BMD accurately and precisely, are
available to diagnose osteoporosis.
Dual-Energy X-ray Absorptiometry (DEXA) is presently regarded as the gold
standard for assessing bone mineral density. This method determines areal
bone density (g/cm2) of the spine, hip, wrist and total body. Bone mineral density
measurements can thus be used to confirm a diagnosis of osteoporosis, to
assess the risk of fracture, to guide the choice of treatment and to follow the
response to specific therapy.
Other bone density techniques include single photon absorptiometry (SPA,
quantitative computed tomography (OCT) and bone ultrasound. SPA, measures
bone mass of the wrist and forearm. This is useful to predict fracture risk of the
specific site measured, but does not always provide accurate information about
bone density at other skeletal sites. OCT, accurately measures spinal bone
mass. This technique is expensive, the radiation dose is higher and
measurements are less reproducible compared to DEXA. Calcaneal Ultra Sound
measures appendicular bone mass and possible bone quality. The technique
provide useful information of fracture risk, but there is concern with regard to
precision and accuracy and its. role in the routine evaluation of osteopenic
patients remains unsure.
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Conventional radiography (X-rays) cannot be used to assess fracture risk, since
bone loss is only apparent when the BMD has decreased by about 30-50%. X-
rays are however essential to confirm the diagnosis of a fracture.
5.3. Bone turnover
5.3.1. Biochemical assessment
Biochemical evaluation of bone metabolism plays an important role, both in the
prevention and treatment of osteoporosis. An increase in bone turnover
significantly contributes to fracture risk independent of the BMD.
Specific biochemical markers have been developed to assess both bone
formation and resorption. The most commonly used markers of bone formation
are bone alkaline phosphatase, osteocalcin and carboxy-terminal propeptide of
type I procollagen (Kanis et aI, 1997; Swaminathan, 1997). The sensitivity and
specificity of alkaline phosphatase are limited because the bone isoforms
comprise only about 40% of the total activity (Swanimathan, 1997). The sensitive
and specific collagen crosslink molecules and telopeptides of collagen I (the
pyridinolines) measured in urine, and recently also in plasma, are used to assess
bone resorption (Kanis et et, 1997; Swaminathan, 1997).
These biochemical indices provide a non-invasive and sensitive method to
determine bone turnover and to further define an individual's fracture risk
although they cannot be employed to confirm a diagnosis of osteoporosis.
5.3.2. Histological assessment
Static and dynamic parameters of bone turnover can be obtained via histological
evaluation of time-spaced tetracycline labelled iliac crest bone biopsies
(Compston, 1997). This is however, an invasive procedure and not routinely
used to assess patients with osteoporosis. It remains the only method to
diagnose mineralization defects (osteomalacia) in patients with osteopenia.
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6. Management of Osteoporosis
Specific medical therapies are currently available to prevent and treat
osteoporosis. Apart from specific pharmacologic therapy, it is also important to
minimize modifiable risk factors by establishing a healthy lifestyle.
6.1. Life style modification
Life style adaptations to be recommended include:
Balanced diet, rich in calcium
Regular exercise, preferably weight-bearing
Stop smoking
Decrease alcohol intake
In the elderly with an increased tendency to fall, measures to prevent falling are
also very important. External protection of the hip employing hip pads has been
shown to significantly reduce hip fracture risk in the elderly (Nevitt and
Cummings, 1993)
6.2. Pharmacologic Treatment
Drugs used to treat osteoporosis can be broadly grouped into those that
decrease bone resorption and those that increase bone formation.
Anti-resorptive drugs act by decreasing the imbalance between bone resorption
and formation, largely decreasing the overall rate of bone turnover. Anti-
resorptive drugs include: calcium and vitamin D supplements, hormone
replacement therapy, bisphosphonates and calcitonin (Riggs and Melton, 1992;
Kanis et aI, 1997).
Bone formation agents increase both the rate at which new bone-remodelling
units are activated and the activity of individual osteoblasts. These agents have
a greater potential to increase bone mass above the fracture threshold and are
theoretically of greater importance in patients with severe bone loss. Formation-
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stimulating drugs presently in use include sodium fluoride and anabolic steroids
(Riggs and Melton, 1992).
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B. EATING DISORDERS
1. Introduction
The eating behaviour of individuals and even populations varies enormously. If
an individual's eating pattern results in self-starvation or includes bingeing and
vomiting, thereby compromising their physical and mental health as well as their
quality of life, it may be indicative of an eating disorder. Another essential feature
of all eating disorders is the relentless pursuit of thinness accompanied by
intense, pathological fear of gaining weight. It is important to recognise that
these disorders are associated with considerable morbidity, affecting almost
every system in the body and that they may prove to be fatal. The death rate,
apart from suicide, has been reported as 9% (Fonseca, 1993; Becker et at, 1999)
and these disorders are therefore of great public health concern.
2. Epidemiology
The prevalence of eating disorders varies greatly among different population
groups. In South Africa these disorders occur primarily in the white middle class
population. It is rare in the coloured population and extremely rare in the black
population, most likely due to different socio-cultural forces (Ziervoge/, 1990).
This seems to be changing due to influences of westernisation (Gard and
Freeman, 1996). The demographic features of anorexia and bulimia suggest that
the cultural value placed on thinness in the Western society plays a central role
in the development of these disorders (Herzog and Cope/and, 1985). It occurs
10 to 20 times more often in females than in males (Hoek, 1995).
3. Etiology
The etiology of eating disorders is considered to be multifactorial. It is generally
acknowledged that a combination of biological, psychological and social factors
contribute to the development of eating disorders (similar to many psychiatric
disorders ).
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Biological factors:
Endogenous opioids may contribute to the denial of hunger in patients with AN.
Starvation causes biochemical changes, (such as hypercortisolemia not
suppresed by dexamethasone), which are also present in depression (Sharp and
Freeman, 1993). Thyroid function is also suppressed (St¢ving et aI, 1998a).
Starvation produces amenorrhoea, which reflects decreased sex hormone levels.
Some investigators have attempted to associate cycles of bingeing and purging
with abnormalities in neurotransmitter secretion and function (Newman and
Halmi, 1988). Because plasma endorphin levels are elevated in some BN
patients who vomit, the feeling of wellbeing after vomiting that some of these
patients experience may be mediated by raised endorphin levels. Abnormalities
in serotonergic function have also been implicated in eating disorders (Kaye,
1995; Pirke, 1995).
Social factors:
Patients with eating disorders (AN and BN) often tend to be high achievers and
respond to social pressures to be slender. As with AN patients, many patients
with BN are depressed and have an increased incidence of familial depression,
althoug the families of patients with bulimia nervosa are generally more
conflictual than the families of AN patients. Patients with BN may describe their
parents as neglectful and rejecting with low levels of nurturing and empathy
(Gard and Freeman, 1996).
Psychological factors:
Anorexia nervosa appears to be a reaction to the demands requiring adolescents
to behave more independently and to increase their social and sexual
functioning. These patients may lack a sense of autonomy and selfhood. Many
experience their bodies as being under the control of their parents, so that self-
starvation may be an effort to gain validation as a unique and special person.
Patients with BN, like those with AN, have difficulties with adolescent demands,
but BN patients are generally more outgoing, angry and impulsive (Fahyand
Eisler, 1993). Alcohol abuse, shoplifting and emotional instability are associated
with BN. Patients with BN may lack the control and ego strength of their
counterparts with AN. Their difficulties in controlling their impulses are often
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manifested by substance abuse and self-destructive sexual relationships, in
addition to the binge eating and purging that are the hallmarks of the disorder.
Many BN patients have histories of difficulties in separating from caretakers. The
struggle for separation from a maternal figure is thought to be played out in the
ambivalence towards food: eating may represent a wish to fuse with the
caretaker, and regurgitating may unconsciously express a wish for separation
(Vandereycken, 1995).
4. Classification
Based on the criteria of the American Psychiatry Association's Diagnostic and
Statistical Manual (OSM IV, 1994), eating disorders are classified into three
groups, each with its own subdivisions: anorexia nervosa (AN), bulimia nervosa
(BN) and eating disorder not otherwise specified (EDNOS).
4.1. Anorexia nervosa (AN)
Anorexia nervosa is a psychiatric syndrome characterised by severe restriction of
food intake due to a pathological fear of weight gain. This results in excessive
weight loss and refusal to maintain a normal body weight. The diagnostic criteria
for AN include a deficit in body mass of at least 15% below expected weight, the
presence of amenorrhoea of at least 3-months duration and body image
distortion (OSM IV, 1994). The term anorexia ("lack of appetite") to describe this
condition is misleading, because there is no decrease in appetite until a very late
stage of the illness (Garfinkel, 1995). The pursuits of a decreased weight are
due to reasons other than loss of appetite. Patients with AN often exercise
excessively (e.g. cycling, jogging and running) in another attempt to reduce
weight.
Anorexia nervosa can be subdivided into two types, the restricting type and the
binge-purging type. In the restricting type, affected individuals restrict intake, but
do not regularly engage in binge eating or purging by self-induced vomiting or
using laxatives or diuretics. In the binge-purging type, affected individuals
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regularly engage in binge eating and purging. Unlike subjects with BN both types
of AN patients fail to maintain a normal body weight.
Anorexia nervosa usually starts in the midteens, but 5% of patients present in
their early 20s. The majority (90%) of patients with this eating disorder are of the
female gender (St¢ving et aI, 1998a). It is estimated that AN affects about 0.28
to 1% of adolescent girls worldwide (Hoek, 1995). It occurs most frequently in
developed countries and is seen most commonly amongst females pursuing a
career that requires thinness such as modelling and ballet (Gard and Freeman,
1996).
4.2. Bulimia nervosa (BN)
The name 'bulimia' comes from the Greek words 'bous' (ox) and 'limos' (hunger).
i.e. ox appetite. Essential features of bulimia nervosa are recurrent episodes of
binge eating, a sense of lack of control over eating during the eating binges, self-
induced vomiting, the misuse of laxatives or diuretics, fasting, or excessive
exercise to prevent weight gain and persistent self-evaluation in terms of body
shape and weight (DSM IV, 1994).
Bulimia nervosa can be subdivided into two types, the purging and non-purging
type. The purging type shows recurrent compensatory behaviour such as self-
induced vomiting or repeated laxative or diuretic abuse. The non-purging type
uses methods like fasting or excessive exercise to prevent any weight gain.
These patients maintain a normal body weight. A diagnosis of BN requires the
presence of both binge and compensatory behaviour, at a frequency of at least
twice a week for 3 months (OSM IV, 1994).
Bulimia nervosa is more prevalent than anorexia nervosa and occurs in 1 to 3
percent of young women. Like anorexia nervosa, bulimia nervosa is more
common in women than in men. It often starts later in adolescence than
anorexia nervosa. This disorder appears to reflect social influences rather than a
genetic predisposition (Fahy and Eisler, 1993).
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4.3. Eating disorder not otherwise specified (EDNOS)
Eating disorder not otherwise specified is a category used to describe eating
disorders that do not meet the criteria necessary to diagnose a specific eating
disorder (OSM IV, 1994).
Examples include recurrent episodes of binge eating without the compensatory
behaviour typical of BN; females meeting all the criteria for AN, except
amenorrhoea; those who meet all the criteria for AN except that their current
weight is in the normal range (OSM IV, 1994).
5. Medical complications of eating disorders
5.1. Acute
Eating disorders can result in acute medical complications e.g. fluid and
electrolyte disturbances most commonly resulting from vomiting and substance
abuse, and acute renal failure.
5.2. Chronic
The longterm effects of eating disorders include:
5.2.1. Endocrine and metabolic abnormalities
Endocrine
Hypothalamic hypogonadism, presenting as amenorrhoea, is the most commonly
encountered endocrine disturbance in patients with eating disorders. In some
patients, amenorrhoea precedes weight loss and in many patients, return of
menstruation is delayed after regaining body weight. Hypothalamic
hypogonadism is present in all patients with AN. Although not a diagnostic
feature, many patients with bulimia nervosa also have menstrual disturbances.
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Hypothalamc dysfunction presenting as amenorrhoea is related to a loss of more
than 15% of ideal body weight, or occurs when body fat content drops below a
critical level (Sharp and Freeman, 1993). Hypothalamic hypogonadism is
characterised by low basal levels of plasma luteinizing hormone (LH) and follicle
stimulating hormone (FSH), attenuation of pulsatile gonadotrophin release, as
well as an impaired response to stimulation with gonadotrophin releasing
hormone. This results in reduced ovarian estrogen output. Estrogen deficiency
may have a profound psychological impact and deleterious effects on the
skeleton and cardiovascular systems of affected individuals (St¢ving et aI,
1998a).
Other endocrine abnormalities seen in eating disorder patients appear to be of
limited clinical relevance. Elevated growth hormone values have been
documented in patients with AN and have been ascribed to a reduced production
of insulin-like growth factor (IGF). A 'euthyroid sick syndrome', characterised by
abnormal thyroid functions (low serum T3, normal or low T4 and normal TSH) in
the absence of thyroid disease, occurs in some patients with AN and probably
represents an adaptation to starvation (Newman & Halmi, 1988). Substance
abuse sometimes includes the abuse of thyroid hormones in an attempt to
enhance weight loss and may present as hyperthyroidism
Metabolic
A low basal metabolic rate is a known feature of starvation and AN. Impaired
temperature regulation has been noted in anorectics, particularly the automatic
changes required to respond to changes in environmental temperature. On
exposure to cold, they do not increase their core temperature, stabilise
temperature or shiver. On exposure to heat there is absent vasodilation and an
abnormal elevation in core temperature (Sharp and Freeman, 1993).
Glucose metabolism is altered and hypoglycemia may occur in patients with
marked malnutrition. Depletion of glycogen and fat stores prolongs recovery
following a hypoglycemic event.
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Lipid abnormalities have been described in eating disorder patients, but the
findings of different studies are conflicting (Sanchez-Munix and Marcus, 1991;
Affenito et aI, 1997). Weight loss appears to be an important cause of changes in
serum lipids. In the overweight individual, it usually results in a prompt decline in
triglycerides and a later rise in HDL-cholesterol as ideal weight is approached.
Serum cholesterol has been shown, however, to rise in humans subjected to
short periods of total starvation.
Hypercholesterolemia is a complex issue. The genetic background of a study
population must always be considered when interpreting study findings. It is
important to remember to distinguish between the different eating disorder
groups when evaluating serum lipid levels.
Significantly higher plasma total cholesterol concentrations are more common in
AN than in the other eating disorder groups (Sullivan et aI, 1998; Mehler et aI,
1998). About 40% of patients with AN have elevated levels of total serum
cholesterol and LDL cholesterol (Stone, 1994). The hyperlipidemia observed is
probably a result of decreased faecal excretion of bile acids and cholesterol.
Given the tendency for eating disorders, like AN, to have a chronic course, such
elevated cholesterol concentrations could potentially increase the risk of coronary
heart disease and stroke in these women.
Data have been published which suggest that the hyperlipidemia is strictly an
acute phase finding and tends to normalise in the chronic period of AN (Sanchez-
Munix and Marcus, 1991). If the latter is true, hyperlipidemia in eating disorder
patients should be managed conservatively. Should LDL-Cholesterollevels be
very high or multiple risk factors for coronary heart disease be present, active
intervention should be undertaken.
5.2.2. Gastrointestinal complications
The gastrointestinal tract is commonly involved, particularly in patients with
bulimia. Dental erosions with poor gum hygiene are common. Malnutrition-
induced parotid enlargement is present in 25% of patients with bulimia and is
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also seen in AN (Sharp and Freeman, 1993). Vomiting may result in
oesophageal tears. The stomach is dilated in binge eaters and occasionally,
gastric rupture occurs. Chronic laxative abuse leads to severe constipation and
eventually to a huge, dilated colon (Fonseca, 1993).
5.2.3. Renal complications
Electrolyte and fluid disturbances (e.g. hypokalaemia, hyponatraemia,
hypochloraemia, hypochloraemic metabolic alkalosis and hyperphosphataemia)
(Sharp and Freeman, 1993) occur frequently in patients with eating disorders,
especially in those with a purging type disorder. This may rarely result in renal
failure (Fonseca, 1993).
5.2.4. Cardiac complications
Cardiac abnormalities may occur at some stage of anorexia in up to 87% of
patients (Sharp and Freeman, 1993). The cardiac complications of anorexia and
bulimia vary from minor electrocardiographic abnormalities to a decrease in
cardiac size with thinning of the left ventricular wall, cardiac failure and life-
threatening arrhythmias. Arrhythmias are caused by electrolyte disturbances
especially hypokalaemia, hypocalcaemia and hypomagnesaemia. These
electrolyte abnormalities are mainly seen in the purging type of eating disorder
characterized by substance abuse.
5.2.5. Neurological complications
Neurological manifestations, similar to the cardiac complications, are secondary
to electrolyte disturbances (e.g. hypokalaemia) and usually comprise muscle
wasting and weakness. Hypocalceamia and hyponatraemia may lead to a variety
of acute neuropsychiatric problems, including epileptic convulsions (Fonseca,
1993).
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5.2.6. Dermatological complications
Gupta et al divided the dermatological signs of eating disorders into three groups.
Those resulting from 1. Malnutrition (dry skin, lanugo, carotenodermia) 2. Self-
induced vomiting (purpura, bruising, calluses on the dorsum of hands) and 3.
Abuse of laxatives and diuretics (Sharp and Freeman, 1993).
5.2.7. Skeletal complications
Osteopenia is a well known complication of eating disorders like AN. The
pathogenesis, clinical relevance and appropriate therapy remain largely unknown
and are discussed in the next section.
Stellenbosch University http://scholar.sun.ac.za
24
C. OSTEOPOROSIS IN EATING DISORDER PATIENTS
1. Introduction
Osteopenia is a common problem in patients with eating disorders and is known
to be present in more than 50% of patients with anorexia nervosa (Rigotti et aI,
1984; Biller et aI, 1989; Bachrach et aI, 1990; Grinspoon et aI, 1997). Data
regarding the impact of other eating disorders on bone health is, however, very
limited. Bone loss often occurs at a young age and may persist even after
recovery of the underlying eating disorder, thereby predisposing patients to
fractures. Symptomatic compression fractures have, in fact, been reported in
these patients. The mechanism(s) of bone loss in eating disorders, however,
remain controversial. It cannot be assumed that the secondary osteoporosis
documented in young eating disorder patients represents a disease process
similar to the more common osteoporosis encountered in postmenopausal
females. An improved understanding of the pathophysiology of the osteoporosis
that occurs in eating disorders is necessary if more cost- and outcome effective
therapeutic strategies are to be developed.
2. Prevalence of Osteoporosis
Rigotti et al (1984) published the first report of reduced BMO in subjects with AN.
Similar observations have been reported in several studies (Ayers et aI, 1984;
Biller et aI, 1989; Bachrach et aI, 1990; Davies et aI, 1990a; Grinspoon et aI,
1997; Soyka et aI, 1999), but BMO status remains poorly defined in the other
eating disorder subgroups.
The majority of women with AN show evidence of bone loss and approximately
50 percent have bone density measurements greater than 1 standard deviation
(SO) below age and sex-matched controls (Rigotti et aI, 1984; Biller et aI, 1989;
Bachrach et aI, 1990; Grinspoon et aI, 1997). Both hip and spinal bone density
appear to be reduced to a significant degree in subjects with AN, although data
addressing this issue are limited to a single report (Salisbury and Mitchell, 1991).
Significant osteopenia has beer) documented in young women who had AN for
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only one year (Bachrach et aI, 1991). The long-term natural history of bone loss
in AN is not known, but data suggest that a significant degree of osteopenia is
often a permanent consequence of anorexia despite disease recovery (Rigotti et
aI, 1991; Herzog et aI, 1993; Klibanski et aI, 1995; Ward et aI, 1997). However,
some studies have shown that BMD increases (Bachrach et aI, 1991) with
recovery of the illness or weight gain.
The prevalence of significant bone loss in BN and EDNOS are uncertain and the
results are conflicting. Joyce et al. (1990) reported a decreased BMD in BN as
well as EDNOS subgroups, while other studies found that bone mineral values
for bulimics were similar to those of controls (Howat et ai, 1989; Newman &
Halmi, 1989; Davies et aI, 1990a; Carmichael and Carmichael, 1995; Sundgot-
Borgen et aI, 1998).
3. Fractures
3.1. Fracture risk
Studies have shown that a significant number of AN patients have spinal bone
densities at or below the fracture threshold (Riggs and Melton, 1986; Newman
and Halmi, 1988; Salisburg and Mitchell, 1991). Rigotti et al (1991) estimated
that the incidence of fractures among their AN patients was seven times higher
than normal. Several longitudinal studies have revealed different recovery
patterns of low BMD in the clinical course of anorexia nervosa patients with
osteoporosis. Some studies suggest restoration of normal bone mass, with
recovery from AN (Treasure et ai, 1987; Klibanski et ai, 1995). Others suggest
that the improvement in bone density may only be partial (Bachrach et aI, 1990;
Herzog et aI, 1993) or that bone mass remains low despite recovery (Rigotti et aI,
1991; Ward et aI, 1997). This is a cause for concern, even for the majority of
anorectic women who recover, and suggests that a history of an eating disorder
may adversely effect skeletal integrity throughout life and constitute a risk factor
for the premature development of osteoporotic fractures. Ward et al (1997)
measured bone density of the hip and lumbar spine in 18 eating disorder women
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who had recovered from their disease, and documented osteopenia in 14 of the
18 women.
3.2. Prevalence of fractures
The prevalence of fractures in eating disorder patients is largely unknown.
Several studies have reported fractures in patients (Table 3) at the time of the
eating disorder, but data regarding long term fracture risk remain controversial.
Recently, the presence of one or more non traumatic vertebral fractures has
been shown to increase the risk of subsequent spine fractures 3-5 fold. In any
patient, the presence of a previous fragility fracture should, therefore, be
regarded as a risk factor for future fracture independent of the prevailing BMD.
The earlier the age of fracture and the greater the number of previous fractures,
the greater the subsequent risk (Kanis et aI, 1997).
Table 3: Reported fractures in eating disorder patients
Studies: Authors (Date) Eating disorder Site of fractures
Ayers et ai, 1984 AN Vertebral compression
Rigotti et ai, 1984 AN Vertebral compression
Crosby et ai, 1985 AN Non specified
Brotman and Stern, 1985 AN Vertebral compression
Szmukler et ai, 1985 AN Vertebral compression
Kaplan et ai, 1986 AN Hip
Treasure et ai, 1986 AN Vertebral, hip
Baum et ai, 1987 AN Femoral neck
Treasure et ai, 1987 AN Not specified
Biller et ai, 1989 NS Vertebral compression
Joyce et ai, 1989 AN,BN Clavicle, wrist, ankle
Hay et ai, 1989 AN Vertebral compression
Olmos et ai, 1990 AN Sternal
Rigotti et ai, 1991 AN Vertebral, hip, metatarsal
Verbruggen et ai, 1993 AN Clavicle
Klibanski et ai, 1995 AN Vertebral compression
Rose et ai, 1999 AN Femural neck
Hartman et ai, 2000 AN Not specified
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4. Bone loss: Cortical versus trabecular
The skeleton is composed of 80% cortical and 20% trabecular bone, the latter
representing the metabolically more active component. Trabecular bone loss
therefore often precedes cortical loss regardless of the underlying etiology. In
women with anorexia nervosa, both cortical and trabecular bone loss have been
documented, although the extent to which this occurs remains unclear. In the
study of Grinspoon et al (1999) spinal and hip bone density measurements were
comparable, suggesting similar involvement of cortical and trabecular bone. In
the study of Carmichael and Carmichael (1995), however, greater involvement of
trabecular bone was shown with spinal bone mineral density measurements
significantly lower than those of hip and total body.
5. Bone turnover
Bone turnover status in eating disorder patients is poorly defined. Data derived
from biochemical testing (Table 4) and histomorphometric analysis reveal
conflicting results with both high and low bone turnover states reported in the
literature (Rigotti et ai, 1984; Kaplan et ai, 1986; Joyce et ai, 1993).
Total serum alkaline phosphatase (ALP) as a marker of bone formation was
reported as normal in 5 of 6 studies (Table 4). Total ALP is however, too
insensitive a marker to really be able to demonstrate the subtle effects of eating
disorders on bone turnover and data must thus be interpreted with caution. In the
three studies using the more sensitive biochemical indices of bone turnover (i.e.
osteocalcin as a marker of bone formation and urinary deoxipyridinoline as a
marker of bone resorption) an uncoupling phenomenon was noted with an
increase in bone resorption accompanied by reduced bone formation - similar to
that seen in some patients with steroid-induced osteoporosis (Fonesca, 1993;
Grinspoon et ai, 1997; Hotta et ai, 2000). These observations differ from those
reported in other populations of estrogen-deficient women in whom the increase
in bone resorption is accompanied by a coupled increase in bone formation
Compston, 1997).
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Table4: Bone formation (Osteocalcin,ALP)and bone resorption
(Oeoxypyridinoline) parameters.
Biochemical Data
Osteocalcin Total ALP Deoxypyridinoline
Author (Date) (bone (bone (bone
formation) formation) Resorption)
Ayers et ai, 1984 Normal
Treasure et ai, 1987 Normal
Fonesca, 1993 Low Normal High
Carmichael & Carmichael 1995 Normal Normal
Crosby et ai, 1995 Normal
Grinspoon et ai, 1996a Low High
Grinspoon et ai, 1997 Low High
Hotta et ai, 2000 Low High
Histological data are very limited, based on only a few observational studies and
case reports, and reveal both high and low turnover states (Rigotti et aI, 1984;
Kaplan et aI, 1986; Joyce et aI, 1990).
6. Proposed etiopathogenesis of osteoporosis in eating disorders
The pathogenesis of osteopenia in eating disorder patients is multifactorial and
appears to be complex. A variety of nutritional factors, exercise abuse, estrogen
deficiency and hypercortisolemia have all been proposed as potential
contributing factors.
6.1. Nutritional factors
Undernutrition and nutritionally dependent factors (malnutrition) may playa
significant role in the bone loss associated with eating disorders. In healthy
normal subjects, short-term fasting over a period of 4 days results in a 50%
reduction in the rate of bone formation (Grinspoon et aI, 1996a). The influence of
nutritional status on bone rnetaboiisrn is also demonstrated by the findings that
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bone density correlates with sensitive nutritional parameters such as body mass
index (BMI), caloric intake, fat mass and leptin levels in women with AN
(Bachrach et aI, 1990; Grinspoon et aI, 1996b). Nutritional factors including a low
calcium and vitamin D intake; high protein, phosphate, caffeine or sodium diet;
high intake of alcohol and low intake of trace elements/vitamins (e.g. fluoride,
vitamin K, vitamin B6, B12, zinc and boron), may significantly contribute to bone
loss in eating disorder patients.
Leptin
The protein leptin is encoded by the obese gene and synthesized by adipocytes
(Clement et aI, 1998). The receptor for leptin is expressed in the hypothalamus,
in which it is proposed to act on the control of feeding (Considine et aI, 1996).
Leptin regulates body weight by influencing energy intake and energy
expenditure. Single meals do not significantly alter leptin levels, whereas
restriction of food intake or short-term fasting and overfeeding have a rapid effect
on leptin synthesis (Nakai et aI, 1999). Plasma levels of leptin are well correlated
with body fat content and body mass index (BMI, kg/m2) in human subjects
(Grinspoon et aI, 1996b; St¢ving et aI, 1998b).
It has been shown that BMI is a reliable measure of body fat in normal and obese
subjects, but this may not be the case in severely emaciated or AN subjects.
Therefore St~ving et al (1998b) suggest that percentage body fat determined by
DEXA scanning is more predictive than BMI in the relationship between
emaciation and leptin levels. A poor correlation was observed between plasma
leptin levels and body mass index (St~ving et aI, 1998b) whereas the correlation
between serum leptin and body fat determined by DEXA scanning was
statistically significant (St~ving et aI, 1998b; Mathiak et aI, 1999). Contrary to this,
Grinspoon et al (1996b) found a highly significant correlation between plasma
leptin and BMI, and Ferron et al (1997) also reported that serum leptin levels in
patients with AN, BN and EDNOS correlated with the individual BMI. Leptin
secretion is not determined solely by the body fat mass. In humans, one day of
overfeeding increased serum leptin and 72h fasting decreased serum leptin. This
clearly demonstrates that the actual feeding status influences the leptin secretion
disproportional to the body fat store.
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It has been reported that AN patients show a severe reduction in plasma leptin
(Grinspoon et ai, 1996b; St¢ving et ai, 1997; Ballingand et ai, 1998; Nakai et ai,
1999) compared to normal controls and bulimic patients (Nakai et ai, 1999). Low
body weight is associated with decreased leptin and this association is
maintained even at an extreme degree of low weight (Grinspoon et ai, 1996b).
Ballingand et al (1998) showed that acute responsiveness of leptin to short-term
refeeding is abolished in AN. This is in contrast with the acute rise of leptin
produced by refeeding in healthy subjects.
Leptin has also been linked to the control of reproduction (Chehab et ai, 1997).
Low leptin levels are associated with past or present episodes of amenorrhoea in
eating disorder females. However, in anorectics the amenorrhoea often precedes
the weight loss and may persist after weight recovery. This suggests that a
criticalleptin level, rather than weight recovery or critical body weight is needed
to maintain menstruation (Clement et aI, 1998). Leptin is required not only for the
regulation of body weight but also for sexual maturation and is therefore a critical
link between energy stores and hypothalamic pituitary functions in humans.
Insulin-like-growth factor-1
One mechanism by which nutritional deprivation may alter bone metabolism,
involves its effect on serum insulin-like-growth factor 1 (IGF-1) concentrations.
Insulin-growth factor 1 (IGF-1) is a nutritionally regulated bone trophic hormone
produced in the liver. Serum levels decrease acutely with caloric deprivation and
are decreased in patients with AN. This hormone has potent effects on bone
growth and is known to stimulate osteoblast function and collagen synthesis in
vivo and in vitro (Rigotti et ai, 1991; Grinspoon et ai, 1996a). Patients with AN are
markedly IGF-1 deficient and serum levels of IGF-1 decrease with weight loss,
increase with weight recovery and predict bone loss (Klibanski et ai, 1995;
Grinspoon et ai, 1996a). Altered IGF-1 may, therefore, constitute a critical
element in the pathogenesis of decreased bone formation and osteopenia in
eating disorder patients.
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Macronutrients
Patients with AN have a daily total energy and macronutrient (protein, fat,
carbohydrate) intake which is significantly lower than controls (Gwirtsman et aI,
1989). The percentage intake of protein, fat and carbohydrate, however, appears
to be similar to that of normal controls.
Calcium
Calcium homeostasis is essential for the maintenance of a healthy skeleton and
calcium malnutrition may therefore contribute towards the decreased BMD
observed in patients with eating disorders. A poor calcium intake is known to
result in secondary hyperparathyroidism and to increase biochemical markers of
resorption, reflecting the increase in bone remodelling activity (Kiriike et aI,
1992). Data on calcium metabolism in patients with eating disorders are however
conflicting. Dietary intake of calcium has been reported to be low (Crosby et aI,
1995) or normal (Howatt et aI, 1989) while urinary calcium excretion has been
shown to be either increased (Abrams et aI, 1993) or comparable to controls
(Kaplan et aI, 1986; Olmos et aI, 1991). Carmichael and Carmichael (1995) found
that calcium excretion was lower in patients with bulimia compared to those with
AN, but provided no explanation for this observation.
As expected, serum calcium levels have generally been within normal limits, and
calcium intakes have not been shown to correlate with BMD in AN (Bachrach et
aI, 1990; Rigotti et aI, 1991; Carmichael & Carmichael, 1995). Moreover, calcium
supplementation has not been shown to increase BMD in this disease (Rigotti et
aI, 1991; Kilbanski et aI, 1995).
Phosphorus
Serum phosphorus levels were found to be slightly lower in women with AN and
BN compared to population norms (Brotman & Stern 1985; Crosby et aI, 1985).
Normal urinary excretion of phosphorus, and no correlation between phosphorus
levels and BMD have been reported in studies of AN (Crosby et aI, 1985; Kaplan
et aI, 1986; Carmichael & Carmichael 1995).
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Vitamin 0
Vitamin 0 metabolism is highly variable in eating disorders since it can be
affected by reduced dietary intake (Crosby et aI, 1985), diminished binding
capacity of vitamin D-binding protein (Olmos et aI, 1992) or a decrease in
vitamin 0 receptors in patients with estrogen deficiency (Liel et aI, 1992).
The majority of studies have demonstrated normal levels of 25(OH) vitamin 0
(Rigotti et aI, 1984; Kaplan et aI, 1986; Olmos et aI, 1991), while some reported
elevated (Carmichael & Carmicheal, 1995) and yet others low or undetectable
levels (Fonesca et aI, 1988; Verbruggen, 1993). Concentrations of 1,25(OH)2
vitamin 0 were lower in patients with AN, compared with controls, in various
studies (Rigotti et aI, 1984; Kaplan et aI, 1986; Fonesca et aI, 1988; Olmos et aI,
1991; Kiriike et aI, 1992). No correlation between BMD and plasma vitamin 0
metabolite levels could be demonstrated. (Rigotti et aI, 1984; Bacharach et aI,
1990; Kiriiki et aI, 1992; Carmichael & Carmichael, 1995). The role, if any, of
vitamin 0 abnormalities in the osteopenia of eating disorder patients, is not clear
at present.
6.2. Mechanical factors
Weight
Low body weight per se would be expected to reduce the strain applied to the
skeleton during normal activities, and may result in a loss of bone mineral.
Therefore body weight is an important factor in the attainment and maintenance
of BMD at all ages. Studies in patients with eating disorders show a consistent
positive correlation between weight expressed as BMI and bone mineral density
(Treasure et aI, 1986; Bachrach et aI, 1990; Carmichael & Carmichael 1995;
Hotta et aI, 2000), implying a potentially negative impact of weight loss on bone
mass.
Exercise
Exercise is known to improve bone mass via enhanced mechanical stresses on
bone, and results in improved muscle strength and co-ordination, thereby
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reducing an individual's risk to fall and fracture (Drinkwater et aI, 1984). On the
other hand, excessive exercise, especially in females, may result in suppressed
gonadal function and hypo-estrogenemia. This may result in increased bone
resorption and bone mineral loss.
Physical activity varies greatly amongst eating disorder patients, from sedentary
lifestyles to excessive exercise programmes. Results of the effect of exercise on
bone mass in eating disorder patients are conflicting. Some studies report
moderate exercise to be protective (Rigotti et aI, 1984; Joyce et aI, 1990), and
strenuous exercise to be detrimental (Joyce et aI, 1990), whereas others could
not demonstrate any relationship between BMD and exercise (Bachrach et aI,
1990; Joyce et aI, 1990).
6.3. Hypercortisolism
The mechanisms of glucocorticoid-induced bone loss are complex. A direct effect
of steroids on bone, whereby bone formation and collagen production are
reduced, appears to be the most important mechanism. Other factors include the
negative calcium balance and reduction in sex hormone levels observed in
individuals with hypercortisolism. Although it has been suggested that elevated
cortisol levels may predispose to bone loss in eating disorder patients (Biller et
aI, 1989; Newman and Halmi, 1989; Carmichael and Carmichael, 1995;
Grinspoon et aI, 1996b), scientific data are scant.
Elevated serum and urinary cortisol levels have been described in women with
AN (Newman and Halmi, 1988; Biller et aI, 1989; Newman and Halmi, 1989) as
well as in patients of normal weight who have BN (Mortola et aI, 1989). The
elevated cortisol levels were ascribed to enhanced activity of the hypothalamic
pituitary adrenal axis (Newman and Halmi, 1989). In a recent study of anorexic
patients, 22% of women with severe osteopenia had mildly elevated urinary-free
cortisol levels (Grinspoon et al 1996b). These data suggest that
hypercortisolemia only contributes to the low bone density in a minority of
patients with AN, but requires further study.
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6.4. Hypogonadism
Any form of estrogen deficiency may potentially result in excessive bone loss,
osteoporosis and ultimately in an increased risk of osteoporotic fractures. It is
therefore not surprising that patients with AN, a disorder in which amenorrhoea is
a principle diagnostic feature, were found to have diminished bone mineral
density in numerous studies (Ayers et aI, 1984; Herzog et aI, 1985; Fonesca et
aI, 1988; Davies et aI, 1990; Kirikke et aI, 1992). Fifty percent (50%) of patients
with BN have menstrual irregularities despite being of normal weight, and this
raises the question whether these bulimia patients are also at risk of developing
osteoporosis.
The relationship between estrogen deficiency, osteopenia and increased fracture
risk in the general population has been well established in the literature (Ayers et
aI, 1984). Amenorrhoea, whether secondary to exercise (Drinkwater et aI, 1984),
hypothalamic disfunction, or oophorectomy in young women or to menopause in
older women, is a risk factor for the development of osteoporosis. The
amenorrhoea in patients with AN is most often the result of a decrease in the
pulsatility of gonadotropin-releasing hormone, resulting in hypogonadotropic
hypogonadism and low or undetectable levels of serum estradiol. A threshold
level of weight or body fat is thought to be necessary for normal pulsatility of
gonadotropin-releasing hormone. Attainment of normal weight in AN patients,
however, does not necessarily imply recurrence of normal menses (Hotta et aI,
1998).
Early onset of amenorrhoea and longer duration of the hypogonadal state are
strong risk factors for a decrease in BMD (Kanis et aI, 1997), and spinal BMD
has been shown to correlate negatively with the duration of amenorrhoea in AN
(Biller et aI, 1989,Rigotti et aI, 1991, Baker et aI, 1999). Other authors, however,
could not demonstrate a correlation between BMD and either duration of
amenorrhoea (Joyce et aI, 1990; Bacharach et aI, 1991) or the plasma levels of
estradiol (Joyce et aI, 1990; Rigotti et aI, 1991).
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Since eating disorders often affect young girls, it may result not only in secondary
loss of menses but also in delayed puberty. This may additionally lead to the
arrest of linear growth and contribute to the bone loss experienced by these
individuals. Hypogonadism with resultant hypoestrogenemia must be regarded
as one of the key factors in the pathogenesis of osteopenia in the eating disorder
patient.
7. Management of osteoporosis in eating disorders patients.
Effective prevention and treatment of osteoporosis in eating disorder patients
have not been established, largely because its pathogenesis remains poorly
understood. Clearly further studies are required. Maintenance of normal weight
(Bachrach et ai, 1990; Rigotti et ai, 1991) and a good nutritional state is a
necessary first step. Risk factors pertaining to osteoporosis should be addressed
similar to osteoporosis in the general population. Dietary supplementation,
specifically with regard to calcium and vitamin D should be provided if indicated.
Estrogen is often proposed as a therapeutic option in eating disorder patients
with osteopenia. It cannot be universally recommended, because study data
confirming the efficacy of estrogen in improving bone mass in these patients is
limited (Klibanski et ai, 1986). The decision on estrogen as a treatment modality,
must be made individually for each patient. The role of other bone specific agents
i.e. bisphosphonates and fluoride in the management of osteoporosis in eating
disorders has not been established. Preliminary studies have shown a significant
effect of short-term recombinant-human IGF-1 administration on bone
metabolism in AN. Administration of recombinant-human IGF-1 has a dose-
dependent effect on markers of bone formation and no obvious stimulative effect
on bone resorption at low doses (Grinspoon et ai, 1996a).
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CHAPTER 3
METHODOLOGY
1. Subjects
1.1. Patient recruitment
This study was limited to female Caucasian eating disorder patients, aged 15 -45
years. Patients were recruited from the eating disorder clinic at Tygerberg
Hospital and Kenilworth Mediclinic, as well as referrals from private practitioners.
1.2. Exclusion criteria
Subjects were screened to exclude factors known to independently affect bone
metabolism. Those patients with a history of diseases or medication (e.g.
corticosteroids, anticonvulsants) known to adversely influence bone health were
excluded from the study.
1.3. Diagnosis of Eating Disorder
A total of 59 patients were studied. These patients were classified by a single
specialist psychiatrist and were included in the study if they met the American
Psychiatric Association Diagnostic and Statistical Manual criteria (OSM IV, 1994)
for eating disorders. Three clinical categories emerged: (1) Anorexia Nervosa
(AN), (2) Bulimia Nervosa (BN) and (3) Eating disorders not otherwise specified
(EDNOS).
2. Methods
A bone mineral density measurement, anthropometric data, dietary assessment,
venesection for biochemical evaluation and questionnaires concerning eating
habits and conventional risk factors for osteoporosis were obtained during a
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single visit to the Department of Endocrinology and Metabolism, at Tygerberg
Hospital.
2.1. Clinical assessment
2.1.1. Risk factor analysis
The presence of conventional risk factors for osteoporosis was assessed by
employing an adapted questionnaire. The original questionnaire is used in the
Department of Endocrinology and Metabolism for the screening of possible
osteoporosis patients. The questions were asked and responses noted by the
researcher.
The following risk factors were addressed: Family history of osteoporosis, alcohol
and calcium intake, smoking habits, history of previous fractures, activity level
and menstrual history. (Addendium I & II)
The alcohol intake of the subjects was also obtained from the risk factor analysis
as well as the dietary history of current eating habits, which were analysed to
provide a more detailed picture of the alcohol intake of the subjects.
Exercise was scored by the following criteria, < 1 h/week (low activity), between
1 and 6h/week (moderate activity) and> 6h/week (high activity).
Menstrual history was assessed as follows: (1) age of menarche, (2) time since
last menstrual period, (3) duration of amenorrhoea, defined as the total number
of months since menarche with absent menses. Patients were further
categorised into 3 categories: normal monthly menstrual cycles, amenorrhoea
(no menses for three months or longer) and oligomenorhoea (irregularlscant
menses).
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2.1.2. Diet history
The diet history was obtained by a qualified dietician. The method used was
dietary recall (history of eating habits for a week before admission) obtained
during a personal interview (Addendum III and IV). The Foodfinder program
(Dietary Analysis Software - Medical Technology, MRC) was used to analyse the
diet histories.
2.1.3. Anthropometric assessments
Subjects were weighed on a balance beam scale wearing light clothing without
shoes. They were asked to remove their shoes to record height. Height was
measured with the subject's back to the vertical rod of the scale. Weight and
height measurements were used to calculate body mass index (BMI)*.
* BMI (kg/m2) = Weight (kg) / Height (rrr')
Normal reference values (BraY,1978)
Normal range 20 - 25
Underweight < 20
Overweight
Obese
25 - 30
> 30
Further sub-classification of these categories was not attempted, given the
relatively small numbers of the study population.
2.2. Bone mineral density assessment
Bone mineral density of the lumbar spine (L1-L4) and various areas of the hip
(femoral neck, trochanter, intertrochanter, total hip, and Ward's triangle) was
quantitated employing Dual Energy X-ray Absorptiometry (Hologic QDR-1 000).
The researcher, a trained DEXA technician performed all the scans.
Bone mineral density measurements are conventionally expressed as either an
absolute value (e.g. g/cm2) or a deviation from a specific norm defined as a so-
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called T - or Z - score. A T-score refers to the BMD of a subject compared to
mean BMD of the young adult reference mean. The Z-score compares the BMD
of the individual with that of age and gender matched controls within a specific
ethnic group. As alluded to previously (p10), the WHO's classification of
osteopenia/osteoporosis was designed to provide a practical basis for the
identification of specifically postmenopausal Caucasian women at risk to sustain
fragility fractures. This classification is applicable to children or young individuals
who have not necessarily reached their peak BMD. Furthermore, the comparison
of absolute BMD values in a heterogeneous study population, aged 15-45 years,
is not practical.
In this present study we therefore employed the Z-score (BMD of subjects
compared to age and sex matched controls), similar to previous studies
examining bone mass in patients with eating disorders. Normative date (Z-
scores) for Caucasians have previously been established in our unit (Rene
Blaaw). The S-score of the lumbar spine and total hip were used to define the
bone mass and to divide subjects into two groups which formed the basis of this
study.
Group (1): Those with a normal lumbar BMD (Z- Score within 1 standard
deviation of normal age and sex matched controls).
Group (2): Those with a low lumbar BMD (Z-Score decreased by more than 1
standard deviation below that of age and sex matched controls).
Group (2) was further sub-divided into those with a Z-Score between 1 and 2
standard deviations below the norm (arbitrarily referred to as mild osteopenia for
the purpose of this study) and those with a Z-Score more than 2 standard
deviations below the norm (referred to as more severe osteopenia for the
purpose of this study) of the lumbar spine.
2.3. Biochemical assessment
A fasting venous blood sample was drawn between 10hOO-12hOO in all subjects.
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Fifty millilitres was used for immediate analyses and 20 ml was stored at -70 "C.
A spot urine sample was also obtained, between 10hOO-12hOOon the day of
assessment.
2.3.1. Serum minerals
The following serum mineral and biochemical parameters were analysed using a
multi channel analyzer (Technicon DAX 48): serum-calcium, magnesium and
phosphate.
Enzymatic, timed end-point colorimetric methods were used for calcium
(reaction with o-cresolphtalein), magnesium (xylidyl blue methods) and
phosphate (reduction with ammonium molybdate). The serum calcium was
corrected for albumin employing the following formula: corrected calcium = serum
calcium + [(40-albumin) x 0.025]
Normal laboratory reference values
S-Calcium (albumin corrected) 2.10 - 2.6 mmolll
S-Magnesium
S-Phosphate
0.75 - 1.00 mmolll
0.8 - 1.40 mmolll
2.3.2. Bone turnover
Bone Turnover was assessed by measuring osteocalcin in serum (RIA kits,CIS
Bio International, France) and deoxypyridinoline ( Bayer Immuno 1™) in urine.
Results obtained using the Bayer Immuno 1 system are generally expressed as a
ratio of deoxypyridinoline to creatinine (nMDPD/mM Cr).
Normal laboratory reference values
Osteocalcin 2.7 - 6.9 ng/ml
U-Free DPD/Cr Ratio 1.4 - 13.6 nmollmmol
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2.3.3. Nutritional parameters and vitamin D
Serum albumin was measured with a multi-channel analyser (Technicon DAX
48). Vitamin 0 determination, described by Shephard et ai, 1987, involves a
competitive protein-binding technique, utilising tritiated 25-0H cholecalciferol as
radio-labelled ligand, unlabelled 25-0H cholecalciferol as standard, vitamin D
deficient rat serum as binding protein and dextran-coated charcoal for phase
separation. Typical recoveries are in the region of 90% (CV< 5%) with CV's for
running controls of approx. 6%.
Normal laboratory reference values
S-Albumin 35 -50 gil
25 (OH) Vitamin D > 18 ng/I
2.3.4. Hormonal studies
2.3.4.1. Sex hormones and prolactin
Luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin were
quantitated by a manual method using the IRMA (immunoradiometric assay)
principle with magnetic separation (Serono diagnostics, Switzerland).
Biochemical evaluation of estradiol was quantitated by RIA kits (in house) and
sex hormone binding globulin (SHBG) by an inhouse radiometric method. Total
testosterone quantitation was performed using a coated tube RIA method
(Diagnostic Products Corporation, Los Angeles, USA).
Normal laboratory reference values
S-LH 1.7 - 13.9 Uti (Follicular phase)
17.5 - 49.0 UII (Midcycle phase)
1.0 - 15.8 UII (Luteal phase)
17.9 - 74.3 Uti (Post Menopausal)
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Normal laboratory reference values
S-FSH 1.1 - 7.6 U/I (Follicular phase)
3.7 - 24.9 U/I (Midcycle phase)
0.9 - 5.3 U/I (Luteal phase)
41.0 - 88.3 U/I (Post Menopausal)
95 - 580 pmol/l (Follicular phase)S-Estradiol
S-SHBG
Total S-Testosterone
S-Prolactin
253 - 1336 pmol/l (Midcycle phase)
0.10 187 - 804 pmol/l (Luteal phase)
< 172 pmol/l (Post Menopausal)
50 - 90 nmoll I
0.4 - 2.9nmol/L
3.0 - 16.0 )lg/l
2.3.4.2. Cortisol
The quantitation of serum-cortisol and 24-hour urine free cortisol were
performed using a coated tube Ria method (Incstar Corporation, Stillwater, USA).
Normal laboratory reference values
S-Cortisol pm: 171.1 - 800.4nmol/l
am: 82.8 - 477.5nmol/l
DU-Free Cortisol 55 - 248 nmol/24h
2.3.4.3. Thyroid function tests
Thyroid stimulating hormone (TSH) was quantitated by manual methods using
the IRMA principle with magnetic separation (Serono Diagnostics, Switzerland).
The determination of serum free thyroxin (T4) was carried out using the
Amerelex-MAB kit (Kodak Clinical Diagnostics).
Normal laboratory reference values
TSH 0.47- 6.9 mUll
9.7 - 25.2 pmol/l
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Growth hormone (GH) was quantitated by manual methods using the IRMA
principle with magnetic separation (Pharmacia Diagnostics, Sweden).
Normal laboratory reference values
GH 1 -13.5 mUlL
2.3.5. Lipid profile
Serum-Cholesterol and Triglycerides were quantitated by automated methods
using the Beckman Synchron CX4CE. HDL-Cholesterol was measured after
precipitating LDL and VLDL with dextransulphate and magnesium. The LDL and
VLDL fractions were removed by centrifugation and HDL-Cholesterol
concentrations were then measured. LDL-Cholesterol was calculated employing
the following formula:
LDL-Cholesterol = S-Cholesterol - (Triglycerides/21 .18 + HDL-Cholesterol)
Normal laboratory reference values
S-Cholesterol
S-Triglycerides
S-HDL Cholesterol
HDL:Cholesterol Ratio
HDL:LDL Ratio
S-LDL Cholesterol
3. Statistical analysis
3.8 - 5.7 mmolll
0.9 - 1.97 mmolll
> 0.9 mmolll
> 0.2
> 0.24
0-4.0
All analysis were performed in consultation with a statistician (Dr H Nell).
Statistical analysis was performed by analysing the group as a whole and
dividing the group into the three eating disorder subgroups, as well as into those
with normal lumbar BMD (Z-Score> -1) and those with a low lumbar BMD (Z-
Score <-1).
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Differences between the subgroups of eating disorders were assessed using
Analysis of variance (ANOVA - TURKEY Multiple Comparison Test). To identify
the group that differs significantly (p < 0.05), a post hoc test was performed. The
clinical variables and biochemical parameters of the normal versus low BMD
groups were compared by Students t test for parametric data. Correlations were
calculated by a Pearson correlation coefficient. Results were regarded as
significant at p < 0.05. Unless otherwise indicated, all data are expressed as the
mean ± SO.
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CHAPTER 4
RESULTS
1. Demographic data of the study population
This study included 59 female Caucasian patients (age 15- 45 years) who met
the criteria for eating disorders outlined in the Diagnostic and Statistical Manual
IV (DSM IV) of the American Psychiatric Association. Twenty five of the patients
met the criteria for Anorexia nervosa (AN), 17 for Bulimia nervosa (BN) and 17
for Eating Disorders not Otherwise Specified (EDNOS).
Patients in the different eating disorder groups were all of similar age, but the AN
subjects had a significantly lower body mass index (p = 0.0001) compared to
those with BN or EDNOS.
Table 1: Demographic data of the eating disorder subgroups
Diagnosis AN BN EDNOS
N 25 17 17
Age (yr.) 21.8 ± 9.2 22.5 ± 5.8 23.6 ± 7.8
Weight (kg) 44.2 ± 7.2 56.8 ± 11.1 53.5 ± 8.9
Height (em) 166.1±5.9 166.4±8.5 164 ± 8.1
BMI (kg/em2) 15.9 ± 2.2 * 20.34 ± 2.6 19.85 ± 2.6
Data presented as mean ± SD
*indicates statistical significance (p < 0.0001) compared to BN and EDNOS
2. Bone mineral density (BMO)
Normal bone development does not occur in a linear fashion, but follows a N-
shaped curve with a rapid increase in bone density at the time of puberty and a
corresponding decrease (in women) at the menopause. This means that it is
important to compare bone density in any clinical group with an appropriately
matched control group. This can be done using age-matched norms (expressed
as standardized z-scores).
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2.1. Lumbar spine
The Z-Score (BMO compared to age and sex matched controls) values were
used to define the bone mass and to divide the subjects into two groups which
formed the basis of this comparative study. (1) Those with a normal BMO
(Z-Score within 1 SO of the norm) and (2) those with a low BMO (Z-Score
decreased by more than 1 SO below that of age and sex matched controls).
The BMO results of the different subgroups as well as the total patient population
are summarised in Table 2.
Forty six percent of the total eating disorder group had a BMO more than 1 SO
below that of age and sex-matched controls. Sixty four percent of AN patients
had a low BMO. Of particular interest is the fact that 29.4% of BN and 35.3% of
EONOS patients also had a low BMO. Moreover, severe osteopenia (Z-Score < -
2S0) occurred in 15% of the total patient population or in a third of those with a
low BMO (Table2).
Table 2: Percentage of the total patient population with normal and low lumbar
(L1 - L4) BMD (mild and severe osteopenia)
Diagnosis AN BN EDNOS Total
n (%) 25 17 17 59
Absolute BMD (g/cm2) 0.689 ± 0.12 * 0.975 ± 0.16 0.936 ± 0.1 0.918 ± 0.14
(1) Normal BMD
9 (36) 12 (71) 11 (65) 32 (54)
Z-Score> -1
(2) Low BMD
16 (64) 5 (29) 6 (35) 27 (46)
Z-Score < -1
(2.1) Mild osteopenia
10 (40) 3 (18) 5 (29) 18 (31 )
Z-Score <-1>-2
(2.2) Severe osteopenia
6 (24) 2 (12) 1 (6) 9 (15)
Z-Score < -2
Data presented as n (%)
Total Lumbar spine (L1-L4)
Z-Score (BMD compared to age and sex matched controls)
BMD (bone mineral density)
*indicates statistical significance (p = 8.03) ANOVA (post hoc)
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2.2. Hip
Due to the lack of normative hip data (Hologic software incomplete) for patients
< 20 years, the left hip BMD assessment of only 32 patients of the total patient
population (59) could be analysed. These results are summarised in Table 3.
Of these patients 56% had a BMD (Z-Score) more than 1 SD below that of age
and sex matched controls. Thirty six percent of BN and 30% of EDNOS patients
had a low hip BMD, whereas 100% of AN patients presented with a low hip bone
mass.
Table 3: Percentage of subjects (n=32) with a normal and low BMD (Left hip)
Diagnosis AN BN EDNOS Total
n (%)
1.Normal BMD
Z-Score >-1
11 11 10 32
0(0) 7 (63) 7 (70) 14 (44)
2.Low BMD
Z-Score < -1
11(100) 4 (36) 3 (30) 18 (56)
Data presented as n (%)
Left Hip (Total)
Z-Score (BMD compared to age and sex matched controls)
BMD (bone mineral density)
3. Clinical risk factor analysis for osteoporosis
3.1. In total eating disorder group and subgroups
It is noteworthy that 24% of the total patient population had a history of previous
fragility fractures (Table 4). A history of amenorrhoea, with mean duration of ±
30.8 months, occurred frequently in the total patient population. All the AN
patients were necessarily amenorrhoeic as this is included in the diagnostic
criteria for AN. Sixty four percent of the bulimic patients and 82.3% of EDNOS
patients presented with a history of amenorrhoea at some stage during their
illness. Amenorrhoea tended to be of longer duration in the AN subjects,
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compared to the other eating disorder groups, and this approached statistical
significance (p = 0.07). Compared to the BN and EONOS groups, alcohol intake
and smoking occurred less frequently in AN patients. Exercise programs
exceeding 6 hrs/week occurred more commonly in the AN patients. Previous
fragility fractures were reported more commonly amongst the AN (28%) and
EONOS patients (29.4%). An acceptable calcium intake was reported by most
patients.
Table 4: Risk factors for osteoporosis in eating disorder subgroups
AN BN EDNOS Total
n 25 17 17 59
Previous fractures n (%) 7 (28) 2 (11.7) 5 (29.4) 14 (23.7)
Family History of OP n (%) 5 (20) 1 (5.8) 4 (23.5) 10 (16.9)
History of Amenorrhoea n (%) 25 (100) 11 (64) 14 (82.3) 50 (84.7)
Duration of Amenorrhoea (mth) 49.4 ± 75.3 23.2 ± 35.0 12.1 ± 13.6 30.8 ± 54.3
Nicotine usage n (%) 6 (24) 10 (58) 9 (53) 25 (42.3)
Alcohol intake n (%) 8 (32) 13 (76) 11 (65) 32 (54.2)
Exercise n (%)
• < 1 hr/wk 6 (24) 1 (5.8) 1 (5.8) 8 (13.6)
• 1 - 6 hr/wk 8 (32) 13 (76.4) 13(76.4) 34 (57.6)
• > 6 hr/wk 11 (44) 3(17.6) 3 (17.6) 17 (28.8)
Low Ca intake n (%) 8 (32) 4 (23.5) 4 (23.9) 16 (27.1)
Data presented as n (%)
Data presented as mean ±SD
3.2. In those with a normal and low BMD
In the normal versus low bone mass groups (Figure1), no significant difference in
age, weight, height or BMI could be demonstrated. Except for the duration of
amenorrhoea (p = 0.0048), conventional risk factors for osteoporosis were similar
in patients with normal and low bone mass. A significant correlation, between
BMI and lumbar BMO (r =0.4; p = 0.0015), as well as hip BMO (r = 0.5; P =
0.001), could be demonstrated in the total eating disorder patient population. We
c
demonstrated a significant negative correlation between duration of amenorrhoea.
and BMO (r = -0.4; P = 0.001) in these patients.
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Risk facor analysis for osteoporosis in normal
and low BMD groups
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Figure1: Risk factor analysis for osteoporosis in subjects with normal and low
lumbar (L1 - L4) BMD. * Indicates statistical significance at p = 0.0048
4. Nutrition parameters
Patients with eating disorders are known to be less than candid about their eating
behaviour. It is also recognised that the "flat slope syndrome" namely the
tendency for subjects to over-estimate what they have eaten when intake is low
and to under-estimate when intake is high, may affect results. The dietary history
of eating disorder patient's must therefore be interpreted with caution. This is
especially noted in the reported total daily energy intakes of the three eating
disorder subgroups, where AN subjects reported the highest and BN patients the
lowest intakes (Table 5).
The nutritional parameters, (Table 5) were similar in the three subgroups, except
for a significantly lower body mass index (BMI) in the AN group (p = 0.0018)
(Table 1). The percentage protein intake of the 3 eating disorder groups was
normal. It is known that AN is not usually associated with inadequate protein
intake, unlike other types of starvation. Our results were in agreement with these
,
findings. Serum albumin, 25 (OH) Vitamin 0 and total serum-cholesterol were
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normal in all the eating disorder patients and did not differ between the
subgroups. Total serum-cholesterol levels were normal in all the eating disorder
patients and it tended to be in the high normal range in patients with AN. Except
for significantly higher S-HDL levels in the AN patients (p=O.03), the lipid profiles
of the three subgroups were comparable. Low triglyceride levels were
documented in all the eating disorder patients.
Table 5: Nutritional parameters for eating disorder subgroups
Normal
laboratory
AN BN EDNOS
reference
values
n 25 17 17
Dietary History (Daily intake)
Energy (kJ) 6163 ± 4870 5083 ± 2849 5490 ± 3400
Macro nutrients
Energy protein (%) 10 - 20 13.9 14.2 15.5
Energy fat (%) <30 23.8 27.2 21.4
Cholesterol (mg) <300 94.1 ± 75.7 93.8 ± 73.3 124.1 ± 159.1
Energy carbohydrates(%) 50 - 65 59.7 55.9 59.2
Alcohol (g) 8.5± 37.5 7.8 ± 17.2 10.6 ± 43.7
Minerals
Calcium (mg) (%RDA) 1200-1500 (>67%) 733 ± 602 (61) 552 ± 244 (44) 690± 309 (57)
Phosphate (mg) (%RDA) >1200 (>67%) 1080± 1042 (90) 909± 515 (76) 1063.± 639 (89)
Plasma Values
Plasma albumin (g/I) 35- 50 45.54 ± 4.5 45.5 ± 3.8 45.2 ± 2.1
25 (OH) Vit D (ng/ml) >18 27.7 ± 7.6 31.3 ± 13.5 28.8 ± 7.5
Total Cholesterol (mmol/I) 3.8 - 5.7 5.3 ± 1.3 4.7±1.3 4.9 ± 0.8
S-Triglyseride (mmol/I) 0.9-1.97 0.63 ± 0.19 0.82 ± 0.34 0.74 ± 0.33
S-HDL Cholesterol (mmol/I) >0.9 1.57 ± 0.53 • 1.19± 0.31 1.43 ± 0.34
HDL:Cholesterol >0.2 0.30 ± 0.07 0.26 ± 0.06 0.29 ± 0.06
HDL:LDL >0.24 0.48 ± 0.17 0.42±0.14 0.47±0.14
S-LDL Cholesterol (mmol/I) 0-4.0 3.40 ±0.93 3.10 ± 1.18 3.16 ± 0.65
Data presented as mean ± SD
* indicates statistical significance (p =:-'0.03)compared to BN and EDNOS
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No evidence of malnutrition could be documented in osteopenic subjects. Mean
body mass index (BMI), total energy intake, macro nutrients, minerals like
phosphate, Vitamin D (Ilg) intake as well as plasma albumin and 25 (OH) Vitamin
D levels were identical in osteopenic and non-osteopenic patients groups.
Calcium intake in both groups tended to be low and was in fact significantly lower
in those with a normal BMD. Total serum cholesterol was higher in those with a
low bone mass. Patients with a low BMD consumed significantly more alcohol
than those with a normal BMD (Table 6).
Table 6: Nutritional parameters of normal versus low BMD groups
Normal BMD
Normal laboratory
Low BMD
reference values
N 32 27
Dietary History (Daily intake)
Energy (kJ) 4792± 3288 6561± 4672
Macro nutrients
Total protein (%) 15.9 10 - 20 13.3
Total fat (%) 25.5 <30 22.8
Cholesterol (mg) 110.7±124.2 <300 95± 84.8
Total carbohydrates(%) 59.8 50 - 65 57.8
Alcohol (g) 1.3±4.1 17.1 ± 48.9*
Minerals
Calcium (mg) (%RDA) 528 ± 244 (44) 1200-1500 (>67) 819 ± 545* (68)
Phosphate (mg) (%RDA) 881.2 ± 567(73) >1200 (>67) 1186± 967 (98)
Plasma Values
Plasma albumin (gil) 45.41 ±3.39 35 - 50 45.45 ± 4.1
25 (OH) Vit D (ng/ml) 29.86 ± 10.8 >18 28.07 ± 8.08
Total Cholesterol (nmol/l) 4.7 ± 1.0 3.8 - 5.7 5.3 ± 1.2 *
S-Triglyseride 0.67 ± 0.24 0.9-1.97 0.77 ± 0.37
S-HDL Cholesterol 1.36 ± 0.34 >0.9 1.5 ± 0.53
HDL:Cholesterol 0.29 ± 0.05 >0.2 0.29 ± 0.07
HDL:LDL 0.47±0.13 >0.24 0.46±0.18
S-LDL Cholesterol 3.05 ± 0.91 0-4.0 3.47 ±0.91 *
BMI 16.6±3.21 17.7 ± 3.01
Data presented as mean ± SD
"* indicates statistical significance of p< 0.05 compared low BMD versus normal BMD
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5. Biochemical Assessment
5.1. Serum Minerals
Serum minerals were similar in the different eating disorder subgroups.
Serum minerals were comparable amongst subjects with a normal and low bone
mass, except for a slightly, albeit significantly higher (p = 0.018) phosphate in the
osteopenic subjects. Mean phosphate levels documented for both groups were
still within normal reference values.
Table 7: Serum minerals in subjects with a normal and low BMD
Normal BMD
Normal laboratory
reference values
Low BMD
Total Ca (mmol/I)
Ca (cor Alb) (mmol/I)
Mg (mmol/I)
P04 (mmol/I)
2.37 ± 0.09
2.24 ± 0.07
0.87 ± 0.07
1.27 ± 0.17
2.1 -2.6
2.1-2.6
0.75-1.0
0.8-1.4
2.4 ± 0.09
2.26 ± 0.06
0.89 ± 0.09
1.35 ± 0.15 *
Data presented as mean ± SO
* indicates statistical significance of p= 0.018 compared low BMD versus normal BMD
5.2. Bone Turnover parameters
Bone turnover in these eating disorder patients was assessed by analysis of
serum osteocalcin and urinary deoxypyridinoline. Due to the known diurnal
variation of these bone markers, all samples were collected between 10hOOand
12hOO.The results of markers of bone formation (osteocalcin) and bone
resorption (deoxypyridinoline) are seen in Table 8.
Mean urinary deoxypyridinoline (U-DPD/Cr ratio) was normal and comparable in
those with a low and normal BMD.
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Table 8: Bone turnover parameters in subjects with a normal and low BMD
Normal BMD
Normal laboratory
LowBMD
reference values
s- osteocalcin 8.1 ± 3.8 2.7 - 6.9 nglml 8.5 ± 4.1
U-DPD/Cr Ratio 8.3±2.3 1.4 -13.6nmoVmmol 8.9 ±2.7
dU -Ca/dUCr Ratio 0.38 ± 0.23 2.8 - 3.7 0.51 ± 0.21 *
TRP% 87.6 ± 5.2 85 - 95 84.6±6.4
Data presented as mean ±SD ; TRP% = % Tubular resorption of phosphate
*indicates statistical significance (p=0.05) compared to low BMDversus normal BMD
steocalcin levels were elevated (>6.9) in 60% of the total patient population, but
the levels were similar in those with and without a low BMD (Table 8). In the total
patient population no correlation between body mass index (BMI) and
osteocalcin or between BMD and osteocalcin could be demonstrated. However,
we did find a correlation between osteocalcin and age (r = -0.33; P = 0.013) in
these patient population. The osteocalcin levels of patients who exercised more
than 6hours/week were significantly (p<0.05) higher than those who exercised
less than 6 hours (Figure2).
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Figure 2: Relationship between osteocalcin and exercise
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5.3. Hormonal levels
5.3.1. Sex hormone and prolactin levels
Mean plasma estrogen in patients with eating disorders were low and consistent
with early follicular phase levels (Table 9). Serum gonadotropin, prolactin and
testosterone levels were normal. No correlation could be demonstrated between
BMD and any of the sex hormone levels.
Sex hormone binding globulin (SHBG) was also measured, as a surrogate
marker of estrogen status. SHBG levels tended (p = 0.06) to be lower in patients
with a low BMD. In the AN group, SHBG levels were in fact significantly lower
(p = 0.03) in the osteopenic patients, compared to those with a normal BMD. No
correlation between SHBG and BMI or BMD could be demonstrated in these
patients.
A negative correlation could be demonstrated between serum cortisol and LH
(r = -0.3; P = 0.03), FSH (r = -0.5; P = 0.0001) and E2 (r = -0.3; P = 0.049).
Table 9: Sex hormone and prolactin levels of subjects with normal and low BMD
Normal BMD
Normal laboratory
Low BMD
reference values
95 - 580 170.7 ± 118.2
1.7-49.0 5.5 ± 7
1.1 - 24.9 7.1 ± 10.6
0.4 - 3.1 1.25± 0.81
50-90 62.3± 17.9
3.0 -19.0 5.8 ± 4.2
E2 (pmol/l)
LH (U/I)
FSH (U/I)
Testosterone (nmoI/L)
SHBG (nmol/l)
Prolactin (119/1)
193.7 ± 196
4.5 ± 5.3
4.9 ± 3.2
1.31 ± 1.06
69.7 ± 18.1
9.3 ± 8.9
Data presented as mean ±SD
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5.3.2. Cortisol, growth hormone and thyroid hormones (TSH, T4)
Timed serum and urinary free cortisol levels (expressed per unit creatinine) were
within the normal range in all patients. These values were also similar in subjects
with normal versus low bone mass, as well as in the different eating disorder
patients. Cortisol values (measured in serum and urine) did not correlate with
BMD, but a significant negative correlation between cortisol and osteocalcin (r = -
0.3; P = 0.038) was noted in the total patient population.
Growth hormone (GH), thyroid stimulating hormone (TSH) and serum free
thyroxine (T4) levels were similar in subjects with and without a low BMD.
Table 10: Serum and urine free cortisol levels, growth hormone and thyroid
hormones (TSH, T4) in subjects with a normal and low BMD
Normal BMD
Normal laboratory
reference values
Low BMD
S-Cortisol (nmol/l)
U-Cortisol/u Cr (nmol/l)
Growth Hormone
388.7 ± 243.5
11.1 ± 7.4
9.5± 10.7
1.24 ± 0.78
14.2 ± 2.9
171.1 - 800.4nmol/l VM
7.7 - 15.6 nmol/l
13.5 mUll
0.47 - 6.9
9.7 - 25.7 pmol/l
426.2 ± 202.2
10.5 ± 8.9
9.47 ± 8.1
1.35 ± 0.62
13.6 ± 4.9
TSH
Data presented as mean ±SD
6. Menstrual Characteristics
Age of menarche was comparable in the three eating disorder groups. Of the 59
patients, only one patient presented with primary amenorrhoea. In the total
patient population, 83% of the patients had a history of amenorrhoea at some
stage during their illness. At the time of evaluation amenorrhoea was
documented in 61% of the subjects. The duration of amenorrhoea tended to be
longer in the AN patients (p = 0.07). As per definition, 100% of the AN patients
were amenorrhoeic, whereas 29% and 35% of the BN and EDNOS respectively
were also amenorrhoeic.
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Table 11: Menstrual characteristics of the eating disorder subgroups
AN BN EDNOS Total
n 25 17 17 59
Age at menarche (yr) 12.6 ± 0.9 12.5±1.0 12.9±1.2 12.7±1.0
History of amenorrhoea n(%) 25(100) 11 (64) 13 (76) 49 (83)
Presence of amenorrhoea n(%) 25 (100) 50 (29) 6 (35) 36 (61)
Duration of amenorrhoea (mth) 49.4 ± 75.3 23.2 ± 35.0 12.1 ± 13.6 30.8 ± 54.3
Data presented as mean ±SD
Data presented as n (%)
The age at menarche and a positive history of amenorrhoea were similar in
subjects with a normal and low BMD. At the time of evaluation amenorrhoea
occurred more commonly in patients with a low BMD (78% versus 47%). Of
particular interest was the observation that the duration of amenorrhoea differed
significantly (p = 0.0048) between these two groups. We could in fact
demonstrate a significant negative correlation between the duration of
amenorrhoea and lumbar BMD (Z-Score) in the total patient population (r = -0.4;
P = 0.007), as well as in the different subgroups (AN r = -O.4,p = 0.03; BN r = -
0.6, p= 0.008; EDNOS r = -0.6, P = 0.005).
Table 12: Menstrual characteristics of subjects with normal and low BMD
Normal BMD Low BMD
n 32 27
Age of menarche (yr) 12.7 ± 0.8 12.6 ± 1.2
History of amenorrhoea n(%) 25 (78) 23 (85)
Presence of amenorrhoea n(%) 15(47) 21 (78)
Duration of amenorrhoea (mth) 12.4±16 53.5 ± 74*
Data presented as mean ±SD
Data presented as n (%)
* indicates statistical significance (p = 0.009)
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Amenorrhoea was of longer duration in the osteopenic patients compared to the
patients with a normal bone mass in the AN and BN groups as seen in Figure 3.
Duration of amenorrhoea (months)
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Figure 3: Duration of amenorrhoea in the subgroups with normal and low lumbar
(L 1 • L4) BMD.
Figure 4 compares body weight, mean serum estradiol and average lumbar BMD
in patients with normal menses (Group1), those with oligomenorrhoea i.e.scant
or absent menses, but not for periods of 3 months or longer (Group 2), and those
with secondary amenorrhoea i.e. absent menses for a period of 3 months or
longer (Group 3).
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Compared to subjects with a normal menstrual cycle, those with
oligomenorrhoea and especially those with amenorrhoea had significantly lower
weight (p=0.006), body mass index (BMI) (p = 0.0008), estradiol levels
(p = 0.017), and lumbar BMD (L1-L4, Z-Score) (p = 0.008) (Figure 4).
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Figure 4: Comparison between weight, BMI, Estradiol and BMD in patients with
normal menses (Group1), oligomenorrhoea (Group 2) and amenorrhoea (Group 3).
The p value is for comparison of Group 1 and Group 3. * Indicates statistical
significant at p < 0.05
Stellenbosch University http://scholar.sun.ac.za
59
CHAPTER 5
DISCUSSION
One of the difficulties in assessing the pathophysiology of eating disorder-
induced osteoporosis involves the diverse way in which these subjects may
manifest clinically. Patients with eating disorders may present for treatment after
6 months or 26 years of illness. Severity can range from those with a normal
body mass index (BMI) with little overt disability to severe emaciation, a BMI of
less than 12 and failure of major organ systems. Onset of disease can occur at
any time from childhood to maturity, although it classically occurs within a few
years of menarche. The impact on the skeleton is likely to vary considerably
depending on these factors. For example, a period of anorexia nervosa (AN)
during childhood is likely to result in stunted growth, whereas onset of the illness
during the late teens and early twenties is likely to result in a failure to attain peak
bone mass and increased risk of developing osteoporosis.
Understanding the pathogenesis of osteoporosis in these patients is further
confounded by the fact that many studies have made no effort to differentiate
between the different categories of eating disorders and have often employed a
heterogeneous study population. In the present study we have paid particular
attention to the correct classification of specific eating disorders - a diagnosis of
anorexia nervosa (AN), bulimia nervosa (BN), or eating disorder not otherwise
specified (EONOS) was made by a single qualified psychiatrist employing the
OSM IV diagnostic criteria (DSM IV, 1994).
In previous studies, the majority of women with AN show evidence of bone loss
and approximately 50% have bone mineral density (BMD) values more than 1
SO below age and sex-matched controls (Rigotti et aI, 1984; Biller et aI, 1989;
Bachrach et aI, 1990; Davies et aI, 1990). Our study is in agreement with these
previous reports of low bone mass in patients with AN. There is little information
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available on changes in BMO in the different eating disorder subgroups. The
effect of bulimia nervosa (BN) on bone mass is largely unknown and both
decreased (Howat et aI, 1989) and normal (Sundgot-Borgen et aI, 1998) BMO
values have been reported. In the present study, low BMO (Z-Score 1 - 2 SO
below the norm) occurred in 64% of AN patients as well as in 30% of BN and
35% EONOS patients. More severe osteopenia (Z-Score < -2 SO) was not
exceptional and occurred in approximately one third of those subjects with a low
BMO.
The bone mass deficit documented in these patients has been shown to manifest
as an increase in skeletal fragility fractures, usually involving the spine, hip or
long bones (Ayers et aI, 1984; Brotman et aI, 1985; Kaplan et aI, 1986; Treasure
et aI, 1987; Biller et aI, 1989; Rigotti et aI, 1991; Klibanski et aI, 1995; Rose et aI,
1999; Hartman et aI, 2000). It has been suggested that patients with AN have a
7X higher incidence of fractures compared with healthy young women (Kaplan et
aI, 1986; Verbruggen et aI, 1993; Rigotti et aI, 1991). It is also known that
patients who have sustained one or more fragility fracture are at increased risk of
subsequent fracture, for any given BMO value (Kanis et aI, 1997). In our study a
history of previous fractures was obtained in 24% of the total patient population
(AN=28%, BN=11.7%, EONOS=29.4%). The average hip BMO of subjects with a
history of fracture (Z-Score = -1.5) tended to be lower than that of individuals with
no fracture history (Z-Score = -0.9), but this did not reach statistical significance
(p = 0.09). This is most likely a function of the small number of fracture subjects,
but may also reflect the temporal relationship between a BMO value obtained at
one point in time and a previous history of fracture, not infrequently sustained
many years previously.
Nature of the osteoporosis
Clinical (lumbar versus hip bone loss) and biochemical (low versus high
bone turnover) parameters to determine the nature of eating disorder-induced
osteoporosis revealed interesting results. Contrary to some previous reports, our
study showed that osteopenia was not confined to the lumbar spine, but also
involved total hip. A low total hip BMO was present in 56% of subjects in whom
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the hip BMD was assessed. Moreover, the degree of hip (Z-Score = -1.66) and
spinal (Z-Score = -1.89) bone loss was comparable in our study, supporting
previous reports (Grinspoon et aI, 1999) that trabecular and cortical bone are
involved to the same extent.
Bone turnover data based on previous studies of patients with eating disorders
suggest an uncoupling phenomenon, with an increase in bone resorption and a
decrease in bone formation (Fonesca et aI, 1993; Grinspoon et aI, 1997; Hotta et
aI, 2000). Reasons for these observations remain unclear, although it is
conceptually feasible that severe malnutrition and hypercortisolemia may be
primarily responsible for the decreased bone formation/osteoclacin levels,
whereas increased bone resorption/deoxypiridinoline excretion may largely
reflect the hypo-estrogenemia known to occur in these patients. Our study could
not confirm this uncoupling in bone turnover and, instead, revealed a modest
increase in serum levels of the bone formation marker osteocalcin, and normal
urinary excretion of deoxypyridinoline, an index of osteoclastic bone resorption.
The young age of this study population may be one of the reasons why the
osteocalcin levels were not decreased as expected. Despite small patient
numbers a negative correlation between serum osteocalcin and age (r = -0.33;
p= 0.013) could in fact be demonstrated in our study. Exercise, is another factor
that may have contributed to the slightly raised osteocalcin levels observed. All
our patients were physically active and 30% exercised more than 6 hours per
week. Osteocalcin levels of patients who exercised more than 6 hours per week
were significantly higher (p < 0.05) than those who exercised less. The decrease
bone formation and increased bone resorption previously documented in patients
with eating disorders have been ascribed, at least in part, to hypercortisolemia.
Our patients, however, had normal serum and urinary free cortisol levels. Finally,
it would appear as if the severity of the malnutrition and emaciation is an
important determinant of bone-turnover in these patients. Hotta et a!. (2000)
claimed that deoxypyridinoline levels were significantly increased, but normalised
in patients when body mass index (BMI) values reached 16.5 to 18.5 kg/m2.
Given the fact that the average BMI of our study population was 18.1 kg/m2, it is
not surprising that their turnover markers were largely within normal limits. The
Stellenbosch University http://scholar.sun.ac.za
62
markers of both resorption (deoxypyridinoline) and bone formation (osteocalcin)
tended to be higher in the osteopenic patients group, compared to those with a
normal bone mass. Although this did not reach statistical significance, the trend
towards an increase in bone markers observed in the osteopenic group, favour a
high turnover pathogenesis and not bone loss due to a reduced formation rate.
Clinical (historic) risk factors
Osteoporosis is a multifactorial disease, largely determined by genetic, life-style
and ageing factors, not infrequently precipitated by bone toxic drugs and lor
medical diseases. In the present study, patients with a history of any medical
diseases or drugs known to adversely influence bone health were excluded. We,
therefore, largely evaluated life-style factors to determine whether they
contributed towards the low BMD observed in 46% of our patient population.
Body weight is an essential factor in the development and maintenance of bone
mass at all ages (Holbrook et aI, 1993). A number of studies in patients with AN
have reported a correlation between BMD and BMI (Treasure et aI, 1986;
Bachrach et aI, 1990) or total body weight (Kiriike et aI, 1992). In the present
study BMD correlated significantly (r = 0.4; P = 0.0015) with BMI. A low BMI
therefore proved to be a major predictor of osteopenia in these eating disorder
patients.
Exercise has a dual effect on bone and both a sedentary life style and excessive
exercise may have a negative influence on bone health, and predict a low BMD
(Joyce et aI, 1990; Kanis, 1994b). All the patients in this study were physically
active, without clear evidence of exercise abuse. No correlation between BMD
and the extent of exercise could be documented.
Alcohol is known to have a direct inhibitory effect on osteoblastic bone formation
and may also adversely influence skeletal integrity via effects on sex hormone
levels, vitamin D metabolism, renal calcium handling and glucocorticoid
homeostasis (Arden, 1997) ..Severe alcohol intake was documented in only one
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AN and three BN patients in our study. However, patients with a low BMD
consumed significantly more alcohol than those with a normal BMD.
A history of amenorrhoea was more prevalent among the AN patients. This is
not surprising given the fact that amenorrhoea is a diagnostic criterion for AN.
Menstrual irregularities were ,however, described in approximately 50% of
women with BN (Sungot-Borgen et aI, 1998). In the present study a history of
amenorrhoea also occurred frequently in the BN (64%) and EDNOS (82%)
groups. There was a significant difference in the duration of amenorrhoea in the
osteopenic subjects compared to those with a normal bone mass. In fact, the
duration of amenorrhoea correlated significantly (r = -0.4; P = 0.001) with BMD in
the total patient population.
The failure of life-style factors such as exercise, dietary calcium intake or
smoking to predict bone density in these patients is not surprising and merely
underscores the fact that these risk factors influence bone mass over many years
and often lack the necessary sensitivity in cross-sectional analyses. The study
did, however, show that a low BMI, alcohol consumption and especially the
presence and duration of amenorrhoea were useful clinical predictors of a low
BMD.
Etiopathogenesis of osteoporosis
The reasons for bone loss in eating disorder patients are multifactorial, complex
and may involve nutritional factors (inadequate calcium intake, low vitamin D,
frank malnutrition), mechanical factors, hypercortisolemia and hypogonadism
(hypo-estrogenemia ).
Nutritional factors
It is well known that undernutriton can markedly decrease osteoblastic bone
formation (Grinspoon et aI, 1996a) and the role of leptin, IGF-I and macro-and
micronutritients in this process has been discussed (see p 27).
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The nutritional assessment of our patients yielded somewhat paradoxical
information. On the one hand, the anthropometric data (BMI) suggested a state
of undernutrition. At the same time, the biochemical data revealed normal serum
albumin, cholesterol and mineral levels. Furthermore, total energy intakes
appeared to be within the normal range. These findings were not consistent with
significant protein calorie malnutrition. The undernutrition of eating disorders is,
however, complex and not strictly comparable to that of classical protein-energy
malnutrition.
It is also known that starvation causes growth retardation, and a decrease in
growth hormone (GH) and osteocalcin levels. Adults who experienced growth
retardation in childhood often have a decreased bone mass even when the BMD
is corrected for their smaller size. Patients included in this study had normal GH
and osteocalcin levels and reached their expected height.
A poor calcium intake has been associated with lower bone mass in population
studies (Gumming, 1990), and may theoretically contribute towards the
pathogenesis of eating disorder-induced osteoporosis. A recent NIH consensus
conference (1994) has proposed a 1200 - to 1500 mg calcium intake as optimal
in adolescents and young adults. On average, our patients consumed 658 mg
calcium per day - i.e. 55% of the RDA. It is known that patients with AN may
adapt to their low dietary calcium, and maintain calcium balance on extremely
low intakes (Gallagher and Riggs, 1978). Moreover, we found no significant
relationship between self-reported calcium intake and measured bone mineral
density in these patients. These results were similar to findings in other studies
(Rigotti et aI, 1984; Biller et aI, 1989; Bachrach et aI, 1990)
Vitamin D metabolism is highly variable in eating disorder. The majority of
studies have demonstrated normal plasma levels of 25(OH) vitamin 0 (Rigotti et
aI, 1984, Kaplan et aI, 1986; Olmos et aI, 1991), while some reported elevated
(Garmicheal and Garnichael, 1995) and yet others low or undetectable levels
(Fonseca et aI, 1988; Verbruggen et aI, 1993). Vitamin 0 deficiency may cause
secondary hyperparathyroidism and mineralization defects. In the present study,
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mean plasma 25(OH) vitamin D levels were, however, well within the normal
range.
In conclusion:
Although it is conceivable that nutritional factors may have contributed initially to
the low bone mass observed in patients with eating disorders, our study provided
no data to suggest that nutritional factors played a significant on-going role in the
development of eating disorder-induced osteoporosis.
Mechanical factors
The role of body weight and physical exercise in the attainment and
maintenance of BMD has been discussed (see p 31). Suffice to point out that in
the present study, body weight expressed as BMI correlated significantly with
lumbar BMD (r = 0.4; p = 0.0015) as well as hip BMD (r = 0.55; P = 0.001), and
that a low BMI was a useful clinical predictor of a low BMD.
Excessive physical exercise is known to be associated with a low BMD in female
as well as male, endurance athletes (Drinkwater et ai, 1984). In the patients
presented here, activity scores were quantitated and excessive exercise was
found to be uncommon. Forty-four percent of the AN patients did exercise more
than 6h/week, whereas only 18% of the BN and EDNOS patients exercised more
than 6h/week. However, data demonstrated that the osteopenic subjects did not
exercise more than those with a normal bone mass. We could also not
demonstrate a correlation between exercise and BMD. These observations are in
accordance with previous reports which generally failed to show a correlation
between exercise and BMD (Biller et ai, 1989; Hay et ai, 1989; Bachrach et ai,
1991. Rigotti et al (1984) in fact suggested that exercise may protect against
bone loss. Our own data, while failing to show a correlation between exercise
and BMD, did document higher osteocalcin values in those patients who
exercised more that 6h/week.
In conclusion:
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While a low body weight may predispose eating disorder patients to osteoporotic
fractures, our study did not incriminate exercise abuse as an important etiologic
factor. If anything, exercise appeared to protect against bone loss.
Hypercortisolism
Glucocorticoids directly inhibit osteoblastic bone formation and indirectly cause a
PTH-mediated increase in bone resorption via effects on intestinal and renal
handling of calcium and a decrease in plasma estrogen levels. Elevated serum
and urinary cortisol levels have been reported in women with AN (Newman and
Halmi, 1988; Biller et aI, 1989, Carmichael and Carmichael, 1995) and BN
(Mortola et aI, 1989).
Due to the single measurement of cortisol, it was difficult to investigate the
contribution of hypercortisolism to bone loss in our eating disorder patients. The
significant negative correlation between serum cortisol and osteocalcin, as well
as a relationship between cortisol and the plasma sex hormones, however,
suggested that our data were indeed valid. None the less, a number of factors
argued against an important role for hypercortisolism in the development of
osteoporosis in these patients. Firstly, neither serum nor urinary free cortisol
levels were found to be elevated in either the total patient population or in those
with a low bone mass. Secondly, neither serum nor urinary cortisol levels
correlated with BMD. Thirdly, biochemical parameters of bone formation and
resorption revealed no evidence of the typical steroid-induced uncoupling
phenomenon.
In conclusion:
A significant negative correlation between serum cortisol and osteocalcin and
between cortisol and plasma sex hormone levels could be demonstrated in our
eating disorder patients and underscores the potential deleterious effects of
hypercortisolemia on bone health. Our data do not, however, suggest a primary
etiologic role for hypercortisolism in the development of eating disorder
osteoporosis.
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Hypogonadism
Estrogen deficiency, regardless of its cause, is a major determinant of BMD, and
has been suggested as one of the key factors in the pathogenesis of osteopenia
in the eating disorder patient. Studies have, however, failed to show a correlation
between serum estradiol concentrations and BMD (Rigotti et aI, 1984; Bachrach
et aI, 1991; Joyce et aI, 1990).
In this present study we observed low serum estradiol levels in our eating
disorder population as a whole, but could not demonstrate a correlation between
BMD and estrogen levels. This is not surprising given the fact that a single
estrogen measurement is not sufficient to assess gonadal status. We therefore
also determined sex hormone binding globulin (SHBG) levels and obtained a
detailed history of menstrual abnormalities and their duration.
Plasma SHBG is increased by estrogen (Goldfien and Monroe, 1997). This
surrogate marker of estrogen status was significantly lower in the AN patients
with a decreased BMD, compared to those with a normal bone mass. Moreover,
we could show that BMD correlated negatively with the duration of amenorrhoea
in our total patient population. This observation is in accordance with the findings
of Biller et ai, (1989), although a number of previous studies have failed to
document this relationship (Joyce et aI, 1990; Bachrach et aI, 1991). Of particular
interest was the observation that all our bulimic patients with a low BMD,
experienced amenorrhoea at some stage during their illness. This is in
agreement with the findings of Howat et ai, (1989) who published the first work
on osteoporosis in BN.
In conclusion:
The presence of amenorrhoea, regardless of the type of eating disorder, was
associated with a significantly lower body weight, BMI, estrogen level and BMD,
compared to subjects with oligomenorrhoea and especially those with normal
menses. SHBG levels were lower in subjects with a low BMD. Estrogen
deficiency is known to cause high turnover osteoporosis - this subset of the
syndrome would not be incompatible with the biomarker data observed in our
patients.
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These observations allowed us to conclude that although nutritional and
mechanical factors as well as hypercortisolism may playa permissive role in the
development of eating disorder osteoporosis, this condition largely results from
chronic hypogonadism.
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CHAPTER 6
1. Study limitations
The present study assessed eating disorder patients in a cross-sectional fashion
employing a single out-patient visit. Moreover, only patients with eating disorders
were included and compared I this study. More detailed evaluation, including the
assessment of appropriate control groups, would have made comparison
between normal and eating disorder patients possible, thereby adding to findings
observed in this study.
Weare confident that interpretation of our BMD data is sound. Precise definition
of the term "osteoporosis" in young, premenopausal subjects remain
controversial. This term has therefore been avoided throughout the text and a I
low bone mass" or "osteopenia" is used instead. We furthermore accept that our
definition of a "low bone mass" and "more severe osteopenia" is an arbitrary one.
Classification of biological variables in terms of 1 and 2 standard deviations
below labove the norm is, however, conventional. None the less, we agree that
the use of Z-scores to assess the risk of future fractures will need to be verified
by prospective studies.
In the present study, we concluded that nutritional and mechanical factors as well
as hypercortisolemia did not contribute significantly to bone loss observed in this
study population of eating disorder patients. Hypogonadism, on the other hand,
appeared to be the main cause of bone loss. We accept that these conclusions
would have been substantiated by the inclusion of a control group. Moreover,
more detailed assessment of nutritional status (e.g. inclusion of serum leptin,
IGF-1 and resistin levels) and glucocorticoid metabolism (e.g. diurnal variations,
dexamethasone suppression tests) would have added credence to our
conclusions.
Finally, we need to take cognisance of the fact that a low BMD is but a risk factor
for development of fracture. The present study did not assess the prevalence of
fractures. The true clinical significance of the alterations in bone and mineral
metabolism observed in these patients with eating disorders therefore remain
unknown.
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Directions for future research
The present study documented a high prevalence of osteopenia in patients with
eating disorders. Longitudinal follow-up of BMD in this population and especially
in those subjects with documented osteopenia, will be of interest. The influence
of an improvement in the eating disorder on BMD will be of particular interest.
The assessment of more sophisticated biochemical parameters of nutrition (e.g.
leptin, IGF-1), as well as the impact of improved nutrition, may yield interesting
information. Moreover, the influence of hormone replacement therapy, especially
in those individuals with documented hypogonadism, one bone health should be
evaluated. Finally, the incidence of skeletal fracture, and the impact of various
nutritional, mechanical and hormonal interventions, in patients with defined
eating disorders should be studied, in order to assess the clinical importance of
this syndrome as a risk factor for the development of osteoporotic fractures.
Stellenbosch University http://scholar.sun.ac.za
71
CHAPTER 7
REFERENCES
Affenito SG, Lammi-Keefe CJ, Vogel S, Backstrand JR, Welch GW and
Adams,CH. Women with insulin-dependent diabetes mellitus (100M)
complicated by eating disorders are at risk for exacerbated alterations in lipid
metabolism. European Journal of Clinical Nutrition 1997; 51: 462-466
Anderson FH and Francis R. Secondary osteoporosis and osteoporosis in men.
In: Arden NK and Spector JD, eds. Osteoporosis Illustrated. London: Current
Medical Literature Ltd., 1997; 121 - 136
Anonymous. Consensus development conference: diagnosis, prophylaxis and
treatment of osteoporosis. American Journal of Medicine 1993; 94: 646 - 650
Arden NK. Risk factors for osteoporosis .. In: Arden NK and Spector JD, eds.
Osteoporosis Illustrated. London: Current Medical Literature Ltd., 1997; 36 - 52
Ayers JWT, Gidwani GP, Schmidt IMV and Gross M. Osteopenia in
hypoestrogenic young women with anorexia nervosa. Fertility and Sterility 1984;
41 (2): 224-228
Bachrach LK, Guido 0, Katzman 0, Litt IF and Marcus R. Decreased bone
density in adolescent girls with anorexia nervosa. Paediatrics 1990; 86 (3): 440-
447
Bachrach LK, Jatznab OK, Litt IF, Guido 0 and Marcus R. Recovery from
osteopenia in adolescent girls with anorexia aervosa. Journal of Clinical
Endocrinology and Metabolism 1991; 72 (3): 602-606
Baker 0, Roberts R and Towell T. Factors predictive of bone mineral density in
eating-disordered women: A longitudinal study. International Journal of Eating
Disorders 2000; 27: 29-35
Balligand JI, Brichard SM, Brichard V, Desager JP and Lambert M.
Hypoleptinemia in patients with anorexia nervosa; loss of circadian rhythm and
Stellenbosch University http://scholar.sun.ac.za
72
unresponsiveness to short-term refeeding. European Journal of Endocrinology
1998; 138:415-420
Baum M, Kramer E and Sange J. Stress fractures and reduced bone mineral
density with prior anorexia nervosa. Journal of Nuclear Medicine 1987; 28: 1506 -
1507
Becker AE, Grinspoon SK, Klibanski A and Herzog DB. Eating Disorders. The
New England Journal of Medicine 1999; 340 (14): 1092-1098
Biller BMK, Saxe V, Herzog DL, Rosenthal 01, Holzman S, Klibanski A.
Mechanisms of osteoporosis in adult and adolescent women with anorexia
nervosa. Journal of Clinical Endocrinology and Metabolism 1989; 68 (3): 548-
554
Bikle ~O. Alcohol-induced bone disease. World Rev Nutr Diet 1993; 73: 53 - 74
Brotman AW and Stern TA. Osteoporosis and pathologic fractures in anorexia
nervosa. American Journal of Psychiatry 1985; 142 (4): 495-496
Callagher JC and Riggs BL. Nutrition and bone disease. New England Journal of
Medicine 1978; 298: 193-195
Carmichael FA and Carmichael DH. Bone metabolism and osteopenia in eating
disorders. Medicine 1995; 74 (5): 254-267
Carter DR, Bouxsein ML and Marcus R. New approaches for interpreting
projected bone densitometry data. Journal of Bone and Mineral Research 1992;
6 (2): 137-145
Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, CassutoD, Gourmelen M,
Dina C, Chambaz J, Lacorte J, Basdevant A, Bougneres 0, LeboucY, Froguel P
and Guy-Grand B. A mutation in the human leptin receptor gene causes obesity
and pituitary dysfunction. Nature 1998; 392 (26): 398-401 (letters to nature)
Chehab FF, Mounzih K and Lu R. Early onset of reproductive function in normal
female mice treated with leptin. Science 1997; 275: 88 - 90
Stellenbosch University http://scholar.sun.ac.za
73
Compston J. The pathogenesis of osteoporosis. In: Arden NK and Spector JD,
eds. Osteoporosis Illustrated. London: Current Medical Literature Ltd., 1997; 17 -
35
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nuce MR,
Ohannesian JP, Marco CC, McKee LJ, Bauer TL and Caro JF. Serum
immunoreactive-Ieptin concentrations in normal-weight and obese humans. New
England Journal of Medicine 1996; 334: 292 - 295
Crosby LO, Kaplan FS, Pertschuk MJ and Mullen JL. The effect of anorexia
nervosa on bone morphometry in young women. Clinical Orthopaedics and
Related Research 1995; 201: 271-277
Cumming RG. Calcium intake and bone mass: a quantitative review of evidence.
Calf Tissue International 1990; 47: 194 - 201
Davies KM, Pearson PH, Huseman NG, Greger NG, Kimmel OK and Recker RR.
reduced bone mineral in patients with eating disorders. Bone 1990a; 11: 143-
147
Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with
amenorrhoea. British Medical Journal 1990b; 301: 790-793
Drinkwater BL, Nilson K, Chesnut III CH, Bremmer WJ, Shainholtz Sand
Southworth MB. Bone mineral content of amenorrheic and eumenorrheic
athletes. The New England Journal of Medicine 1984; 311 (5): 277-281
(DSM IV) American Psychiatric Association: Diagnostic and Statistical Manual of
Mental Disorders (DSM IV), Fourth Edition. Washington, DC, American
Psychiatric Association, 1994
Fahy T and Eisler I. Impulsivity and Eating Disorders. British Journal of
Psychiatry 1993; 162: 193-197
Ferron F, Considine RV, and Peino R. Serum leptin concentrations in patients
with anorexia nervosa. Bulimia nervosa and non-specific eating disorder
correlate with the body mass index but are independent of the respective
disease. Clinical Endocrinology 1997; 46: 289 - 293
Stellenbosch University http://scholar.sun.ac.za
74
Fonseca VA, DaSouza V, Houlder S, Thomas M, Wakeling A, Dandona P.
Vitamin D deficiency and low osteoclacin concentrations in Anorexia Nervosa.
Jou rnal of CIinical Pathology 1988; 41: 195-197
Fonseca VA. Medical complications of anorexia and bulimia. Hospital Update
1993: 68-74
Gard MCE and Freeman CPoThe dismantling of a myth: A review of eating
disorders and socio-economic status. International Journal of Eating Disorders
1996; 20 (1): 1-12
Garfinkel PE. Classification and Diagnosis of Eating Disorders. In: Brownell KD
and Fairburn CG, eds. Eating disorders and obesity. New York: The Guilford
Press, 1995; 125 - 134
Goldfien A and Monroe SE. Ovaries. In: Greenspan FS and Strewler GT, eds.
Basic and Clinical endocrinology. Stamford: Appleton and Lange 1997; 13: 434 -
486
Grinspoon S, Baum H, Lee K, Anderson E, Herzog D and Klibanski A. Effects of
short-term recombinant human insulin-like growth factor I administration on bone
turnover in osteopenic women with anorexia nervosa. Journal of Clinical
Endocrinology and Metabolism 1996a; 81 (11): 3864-3870
Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L,
Bowsher R, Herzog D and Klibanski A. Serum leptin levels in women with
anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 1996b; 81
(11): 3861-3863
Grinspoon S, Herzog D and Klibanski A. mechanisms and treatment options for
bone loss in anorexia nervosa. Psychopharmacology Bulletin 1997; 33 (3): 399-
404
Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D and
Klibanski A. Severity of osteopenia in estrogen-deficient women with anorexia
nervosa and hupothalamic amenorrhea. The Journal of Clinical Endocrinology
and Metabolism 1999; 83 (6): 2049-2055
Stellenbosch University http://scholar.sun.ac.za
75
Gwirtsman HE, Kaye WH, Curtis SR and Lyter LM. Energy intake and dietary
macronutrient content in women with Anorexia Nervosa and volunteers. Journal
of the American Dietetic Association 1989; 89 (1): 54- 57
Hay PJ, Hall A, Delahunt JW, Harper G, Mitchell AW and Salmond C.
Investigation of osteopenia in anorexia nervosa. Aust NZJ Psychiatry 1989; 23:
261 - 268
Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R and Patel S. Bone density
of women who have recovered from anorexia nervosa. International Journal of
Eating Disorders 2000; 28(1): 107 - 112
Herzog DB and Copeland PM. Eating Disorders. The New England Journal of
Medicine 1985; 313 (5): 295-303
Hertzog W, Minne H and Deter C. Outcome of bone mineral density in anorexia
nervosa patients 11.7 years after first admission. journal of bone and Mineral
Research 1993; 8(5): 597 - 605
Hiller S and Cooper C. The epidemiology of osteoporosis. In: Arden NK and
pector JD, eds. Osteoporosis Illustrated. London: Current Medical Literature
Ltd., 1997: 1 -14
Hoek HW. The distribution of eating disorders. In: Brownell KD and Fairburn CG,
eds. Eating disorders and obesity. New York: The Guilford Press, 1995: 207 -
237
Holbrook TL and Barett-Connor E. The association of life-time weight control
patterns with bone mineral density in an adult community. Bone Mineral 1993;
20: 141 - 149
Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T and Takano K. The
relationship between bone turnover and body weight, serum insulin-like growth
factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia
nervosa. The Journal of Clinical Endocrinology and Metabolism 2000; 85 (1):
200-206
Stellenbosch University http://scholar.sun.ac.za
76
Hotta M, Shibasaki T, Sato K, Hizuka N, and Demura H. The importance of body
weight history in the occurrence and recovery of osteoporosis in patients with
anorexia nervosa: evaluation by dual absorptiometry and bone metabolic
markers. European Journal of Endocrinology 1998; 139: 276-283
Howat PM, Varner LM, Hegsted M, Brewe MM and Mills GO. The effect of
bulimia upon diet, body fat, bone density, and blood components. journal of the
American Dietetic Association 1989; 89 (7): 929-934
Joyce JM, Warren DL, Humphries LL, Smith AJ and Coon JS. Osteoporosis in
women with eating disorders: Comparison of physical parameters, exercise, and
menstrual status with SPA and DPA evaluation. Journal of Nuclear Medicine
1990; 31: 325-331
Kaye WHo Neurotransmitters and anorexia nervosa. In: Brownell KD and
Fairburn CG, eds. Eating disorders and obesity. New York: The Guilford Press,
1995: 255 - 260
Kanis JA, Delmas P, Burckhardt P, Cooper C and Torgerson D. Guidelines for
diagnosis and management of osteoporosis. Osteoporosis International 1997; 7:
390-406
Kanis JA. Prevention of Osteoporosis from menarche to menopause. In:
Osteoporosis, Oxford: Alden Press Limited 1994; 148 - 167
Kaplan FS, Pertschuk M, Fallon M and Haddad J. Osteoporosis and hip fracture
in a young woman with anorexia nervosa. Clinical Orthopaedics and Related
Research 1986; 212: 250-254
Kiriike N, Iketani T, Nakaniski S, Nagata T, Inoue K, Okuno M, Ochi Hand
Kawakita Y. Reduced bone density and major hormones regulating calcium
metabolism in anorexia nervosa. Acta Psychiatric Scand 1992; 86: 358-363
Klibanski A and Greenspan SL. Increase in bone mass after treatment of
hyperprolactinemic amenorrhea. The New England journal of Medicine 1986;
315 (9): 542-546
Stellenbosch University http://scholar.sun.ac.za
77
Klibanski A, Biller BMK, Schoenfeld DA, Herzog DB and Saxe VC. The effects of
estrogen administration on trabecular bone loss in young women with anorexia
nervosa. Journal off Clinical Endocrinology and Metabolism 1995; 80 (3): 898-
904
Law M. Preventing osteoporosis. In: Arden NK and Spector JD, eds.
Osteoporosis Illustrated. London: Current Medical Literature Ltd., 1997; 88 - 99
Liel Y, Kraus S, Levy J and Shany S. Evidence that estrogen modulate activity
and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like
cells (ROS 17/2.8). Endocrinology 1992; 130: 2597 - 25601
Mathiak K, Gowin W, Hebebrand J, Ziegler A, Blum WF, Felsenberg D, l.ubbert
Hand Kopp W. Serum Leptin Levels, body fat deposition, and weight in females
with anorexia and bulimia nervosa. Hormone and Metabolic Research 1999; 31:
274-277
Mehler PS, Lezotte D and Echel R. Lipid levels in anorexia nervosa. International
Journal of Eating Disorders 1998; 24: 217-221
Mortola JF, Rasmussen DD and Yen SSC. Alterations of the adrenocorticotropin-
cortisol axis in normal weight bulimic women; evidence for a central mechanism.
Journal of Clinical Endocrinology and Metabolism 1989; 68 (3): 517-522
Nakai Y, Hamagaski S, Kato S, Seino Y, Takagi Rand Kurimoto F. Role of leptin
in women with eating disorders. International Journal of Eating Disorders 1999;
26: 29-35
Nevitte MC and Cumming SR. Type of fall and risk of hip and wrist fractures: the
study of osteoporotic fractures. Journal of American Geriatric society 1993; 41:
1226 - 1234
Newman M and Halmi KA. The endocrinology of anorexia nervosa and bulimia
nervosa. Endocrinology and Metabolism Clinics of North America 1988; 17 (1):
195-207
Newman MM and Halrnl KA. Relationship of bone density to estradiol and cortisol
in anorexia nervosa and bulimia. Psychiatry Research 1989; 29: 105-111
Stellenbosch University http://scholar.sun.ac.za
78
Olmos JM, Riancho JA, Amado JA, Freijanes J and Conzalez-Marcus J. Vitamin
o metabolism and serum binding proteins in anorexia nervosa. Bone 1991; 12:
43 - 46
Osteoporosis Working Group of the SA Medical Association. Osteoporosis
clinical guidelines. South African Medical Journal 2000; 9: 907 - 944
Pirke KM. Physiology of bulimia nervosa. In: Brownell KD and Fairburn CG, eds.
Eating disorders and obesity. New York: The Guilford Press, 1995; 261 - 265
Riggs BL and Melton LJ. Involutional osteoporosis. The New England Journal of
Medicine 1986; 314 (26): 16761686
Riggs BL and Melton LJ. The prevention and treatment of osteoporosis. The New
England of Medicine 1992; 327 (9): 620-627
Rigotti NA, Neer RM, Skates SJ, Herzog DB and Nussbaum SR. The clinical
course of osteoporosis in anorexia nervosa: A longitudinal study of cortical Bone
Mass. JAMA 1991; 265 (9): 1133-1138
Rigotti NA, Nussbaum SR, Herzog DB and Neer RM. Osteoporosis in women
with anorexia nervosa. The New England Journal of Medicine 1984; 311 (25):
1601-1606
Rose M, Hildebrandt M, Schoeneich F, Danzer G and Klapp BF. Severe anorexia
nervosa associated with osteoporotic-linked femural neck fracture and pulmonary
tuberculosis: A case report. International Journal of Eating disorders 1999; 25(4):
463 - 467
Salisbury JJ and Mitchell JE. Bone mineral density and anorexia nervosa in
women. American Journal of Psychiatry 1991; 148: 768-774
Sanchez- Munix FJ and Marcus A. Serum lipids and apo-lipoprotein B values,
blood pressure and pulse rate in anorexia nervosa. European Journal of Clinical
Nutrition 1991; 45: 33 - 36
Stellenbosch University http://scholar.sun.ac.za
79
Shephard GS, Carlini SM, Hanekom C and Labadarios. Analysis of 25-
hydroxyvitamin 0 in plasma using solid phase extraction. Clinica Chimica Acta
1987; 167: 231-236
Sharp CW and Freeman CPL. The medical complications of anorexia nervosa.
Review article. British Journal of Psychiatry 1993; 162: 452-462
Smith EL and Gilligan C. Mechanical forces and bone. Bone and Mineral
Research 1989; 6: 139 - 173
Soyka LA, Grinspoon S, Levitsky LL, Herzog DB and Klibanski A. The effects of
anorexia nervosa on bone metabolism in female adolescents. The Journal of
Clinical Endocrinology and Metabolism 1999; 84 (12): 4489-4496
St~ving RK, Hangaard J, Hansen-Nord M and Hagen C. A review of endocrine
changes in anorexia nervosa. Journal of Psychiatric Research 1998a; 33: 139-
152
St~ving RK, Vinten J, Handberg A, Ebbesen EN, Hangaard J, Hansen-Nord M,
Kristiansen J and Hagen C. Diurnal variation of the serum leptin concentration in
patients with anorexia nervosa. Clinical Endocrinology 1998b; 48: 761-768
Stone NJ. Secondary causes of hyperlipidemia. Medical Clinics of North America
1994; 78 (1): 117-141
Sullivan PF, Gendall KA, Bulik CM, Carter FA and Joyce PR. Elevated total
cholesterol in bulimia nervosa. International Journal of Eating Disorders 1998;
23: 425-432
Sundgot-Borgen J, Bahr R, Falch JA and Sundgot-Schneider L. Normal bone
mass in bulimic women. Journal of Clinical Endocrinology and Metabolism 1998;
83 (9): 3144-3149
Swaminathan R. Biochemical Markers for Osteoporosis. In: Arden NK and
Spector JD, eds. Osteoporosis Illustrated. London: Current Medical Literature
Ltd., 1997; 71 - 87
Stellenbosch University http://scholar.sun.ac.za
80
Szmukler GI, Brown SW, Parsons V and Darby A. Short reports: Premature loss
of bone in chronic anorexia nervosa. British Medical Journal 1985; 290: 26-27
Treasure J, Fogelman I and Russell GFM. Osteopenia of the lumbar spine and
femoral neck in anorexia nervosa. Scottish Medical Journal 1986; 31(3): 206-
207
Treasure JL, Russel GFM, Fogelman I and Murby B. Reversible bone loss in
anorexia nervosa. British Medical Journal 1987; 295: 474-475
Vandereycken W. The families of patients with an eating disorder. In: Brownell
KD and Fairburn CG, eds. Eating Disorders and Obesity. New York: The Guilford
Press, 1995: 219 - 223
Verbruggen LA, Brayland M and Shahabpour M. Osteomalacia in a patient with
anorexia nervosa. The Journal of Rheumatology 1993; 20 (3): 512-517
Ward A, Brown N and Treasure J. Persistent osteopenia after recovery from
Anorexia Nervosa. International Journal of Eating Disorders 1997; 22: 71-75
WHO Study Group. Assessment of fracture risk and its application to screening
for post menopausal Osteoporosis. Osteoporosis International 1994; 4: 368 - 381
Yeager KK, Agostini R, Nattiv A and Drinkwater B. The female athlete triad:
disorder eating, amenorrhoea, osteoporosis. Official journal of the American
College of Sports Medicine 1993; 775-776
Ziervogel CF. Anorexia Nervosa and Bulimia. VMO.CME 1990; 8 (3): 233-242
Younghee K and Linkswiler HM. Effect of levels of protein intake on calcium
metabolism and on parathyroid and renal function in the adult human male.
Journal of Nutrition 1979; 109: 1399 - 1404
Stellenbosch University http://scholar.sun.ac.za
ADDENDUM I
Risikofaktor Vraelys
RAS:
OUDERDOM:
FAMILIEGESKIEDENIS van OSTEOPOROSE:
LlGGAAMSBOU:
Lengte:
Gewig:
LMI:
ALKOHOL:
Aantal sopies per dag:
Geen (0) I Matig - < 4 sopies/dag (1) I Straf - ~ 4 sopies/dag (2)
ROOK:
Aantal per dag:
KALSIUMINNAME:
Geen (0) I Onvoldoende (1) I Voldoende (2)
SISTEEMSIEKTES:
BEENTOKSIESE MIDDELS:
FRAKTUURGESKIEDENIS:
Aantal Frakture:
Tipe Fraktuur:
AKTIWITEITSVLAK:
Tipe oefening:
< 1h/wk:
1 - 6h/wk:
> 6h/wk:
MENSTRUELE GESKIEDENIS:
Ouderdom van menarg:
Siklus:
Absoluut normal (0):
Oligonormaal (1):
Amenoree - afwesigheid van stondes 3mnde of meer (2):
Ouderdom wanneer Amenoree begin:
Duurte van Amenoree:
Kontrasepsie:
Ja I Nee •
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ADDENDUM II
Risk Factor Analysis
GENDER:
RACE:
FAMALY HISTORY OF OSTEOPOROSIS:
ANTROPOMETRIE:
Length:
Weight:
BMI:
ALCOHOL:
Toads per day:
None (0) / Mild - <4 units/day (1) / Severe - ~ 4 units/day (2)
SMOKING:
Cigarettes per day:
CALCIUM INTAKE:
Supplements: yes / no
Diet: none (0) / inadequate (1) / adequate (2)
DISEASES INFLUENCING BONE:
BONE TOXIC DRUGS:
FRACTURE HISTORY:
Number of fractures:
Type of fracture:
ACTIVITY LEVEL:
Type of exercise:
< 1h/wk:
1 - 6 h/wk:
> 6h/wk:
MENSTRUAL HISTORY:
Age of menage:
Cycle:
Normal (0):
Oligomenorrhoea (1):
Amenorrhoea - no menses for the last 3 months (2):
Age of Amenorrhoea:
Duration of Amenorrhoea:
Contraception: '
Yes/No
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ADDENDUM III
Naam:
Diagnose:
Geboortedatu m:
Ouderdom:
DIEET INLIGTING
Gewig:
Lengte:
TYD VOEDSEL ITEM BESKRYWING KODE MASSA
Adapted from: Department of Nutrition, Tygerberg Hospital
'n VEREENVOUDIGE FREKWENSIE VRAEL YS
VOEDSEL ITEM FREKWENSIE HOEVEELHEID
Lekkers
Sjokolade
Koek / Terte
Koekies
Vrugte
Vrugtesap
Droe vrugte
Geblikte vrugte
Chips
Grondbone
Nagereg
Roomys
Suiker
Konfyt
Beskuit
Joghurt
Sprigmielies
Eiers
Milo / Horlicks / Ovaltine
Koeldrank
Melk
Kaas
Alkohol
Adapted from: Department of Nutrition, Tygerberg Hospital
ADDENDUM IV
DIET INFORMATION
Name:
Diagnosis:
Date of birth:
Age:
Weight:
Length:
TIME FOOD ITEM DESCRIPTION CODE MASS
..
Adapted from: Department of Nutrition, Tygerberg Hospital
SIMPHIZE FREQUENCY QUESTIONAIRE
FOOD ITEM FREQUENCY AMOUNT
Sweets
Chocolate
Cake / Tarts
Biscuits
Fruits
Fruit juice
Dried fruit
Can fruit
Chips
Peanuts
Pudding
Ice-cream
Sugar
Jam
Rusks
Yoghurt
Popcorn
Eggs
Milo / Horlicks / Ovaltine
Sodas
Milk
Cheese
Alcohol
Adapted from: Department of Nutrition, Tygerberg Hospital


